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Background: Mesenchymal stem cell (MSC) based cartilage tissue engineering for 
treating articular lesion is of particular interest due to the multipotency for effective 
chondrogenic differentiation. The various applications of three dimensional scaffolds 
and mechanical stimulations aim to promote MSC chondrogenesis in every aspect 
from cell attachment, proliferation to extracellular matrix (ECM) deposition and 
mechanical properties. 
Hypothesis: The general hypothesis of this thesis is that deferral dynamic mechanical 
stimulation is able to enhance chondrogenesis, suppress hypertrophy and potentially 
facilitate zonal distribution in the MSC constructs supported with stepwise upgraded 
elastomeric poly L-lactide-co-e-caprolactone (PLCL) scaffolds. It was broken down 
into three sections of investigation. 
Methods: In vitro studies were conducted on MSC-seeded scaffolds. Chondrogenic 
culture and mechanical stimulation of compression and dual-axis loading were 
applied to constructs. The porous PLCL, unilayered PLCL/chitosan and bilayered 
PLCL/chitosan scaffolds were characterized using SEM, FTIR/TGA and mechanical 
tests. The cell-matrix constructs were evaluated by histological analysis, 
chondrogenic/hypertrophic/zonal mRNAs expression, protein synthesis level and 
mechanical strength analysis. Mechanism of mechanotransduction was studied 
through assessing the regulation of pathway relevant molecules in TGF-β/SMAD and 
integrin β1 signaling. 
 
 
Results: In the first section, chitosan coating on PLCL scaffold increased 
hydrophilicity, which further promoted cell spreading, attachment, distribution and 
condensation. MSC-seeded PLCL/chitosan constructs showed increasing expression 
of collagen type II (COL II) and aggrecan (AGCAN), as well as higher mechanical 
strength. In the second study, deferral dynamic compression enhanced COL II and 
AGCAN deposition and suppressed collagen type X (COL X), matrix 
metallopeptidase 13 (MMP13), alkaline phosphatase (ALP) and Runt-related 
transcription factor 2 (RUNX2) expression. A further investigation on TGF-β/SMAD 
and integrin β1 pathways showed compression promoted phosphorylation of 
SMAD2/3, but down-regulated phosphorylation of  SMAD1/5/8, focal adhesion 
kinase (FAK) and extracellular signal-regulated kinase (ERK). These molecular 
modulations were confirmed by ALK5 and integrin β1 inhibition. In the last results 
chapter, the application of deferral dual-axis (DA) loading to MSC-seeded bilayered 
PLCL/chitosan constructs showed a decrease in AGCAN mRNA expression and an 
increase in COL II staining in the layer with small pore (SP). Subsequent mRNA 
analysis of zonal markers – collagen type I (COL I) and proteoglycan 4 (PRG4) 
exhibited increased expression in SP layer under DA loading, indicating the 
occurrence of ECM zonal deposition. 
Conclusion: Deferral dynamic compression enhanced MSC chondrogenesis in 
hydrophilic unilayered PLCL/chitosan scaffold, and inhibited hypertrophic 
development. The mechanotransduction of compression initiated from transducing 
extracellular physical loading into intracellular biochemical signals through integrin 
 
 
β1 pathway. Then crosstalk between TGF-β/SMAD and integrin β1siganling leads to 
chondrogenic enhancement and hypertrophic suppression through the antagonizing 
roles of TGF-β/Activin/Nodal and BMP/GDP branches. The further application of 
deferral dual-axis loading to bilayered PLCL/chitosan MSC constructs revealed 
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Articular cartilage is an avascular connective tissue which lacks self-repairing 
capacity (Hunziker, Quinn, & Hauselmann, 2002; Muir, 1995). Existing clinical 
approaches to treat cartilage defects are unsatisfactory in terms of the functional 
inferiority(Keeney et al., 2011, Aigner and Stove,2003).Hence, tissue engineered 
cartilage repair with or without scaffold as a promising treatment has been 
progressively investigated(Ahmed and Hincke, 2010, Hunziker, 2009). However, the 
major cell-based method, autologous chondrocyte implantation (ACI), suffers from 
the limitation of defect size, risk of donor-site morbidity and loss of chondrocyte 
phenotype during monolayer expansion(Smith, Knutsen, & Richardson, 2005). Bone 
marrow derived mesenchymal stem cells (MSCs), with high proliferative capability 
and the ability to differentiate to chondrocytes, have been considered as a potential 
alternative cell source. However, the biological characteristics and mechanical 
properties of engineered neocartilage using MSCs are still less optimal than the native 
cartilage. Although a wide variety of bioactive factors, scaffold manipulation, and 
culture conditions has been study to promote MSC cartilage formation, effective and 
reliable strategies yielding tissues with properties matching those of native cartilage 
have not been developed (Keeney etal., 2011, Kock et al., 2012). 
Chondrogenesis of MSCs involves cell recruitment, migration, condensation, 
chondrocyte differentiation and maturation (Goldring, Tsuchimochi, & Ijiri, 2006). 
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This process is precisely controlled by growth factors, transcriptional factors, cell-cell 
and cell-matrix interactions and other environmental factors (Goldring et al., 2006; 
Mahmoudifar & Doran, 2012; Woods, Wang, & Beier, 2007).Under physiological 
conditions, articular motion subjects cartilage to a range of mechanical loading such 
as compressive and shear force, and hydrostatic pressure, causing cell and tissue 
deformation and changes in fluid flow (Kock et al., 2012). Physiological loading is a 
pivotal factor influencing the chondrogenic differentiation of MSCs during articular 
cartilage development, modulating the properties of the cartilage by triggering 
anabolic tissue responses with increased synthesis of ECM components. Cartilage 
regeneration strategies must therefore take into account the biomechanical 
environment and physical stimuli. Despite increasing evidence that shown the 
influence of mechanical stimulation during MSCs chondrogenesis (Grad, Eglin D Fau 
- Alini, Alini M Fau - Stoddart, & Stoddart, 2011; Mouw, Connelly, Wilson, Michael, 
& Levenston, 2007),there remains a huge gap in understanding the contributing 
factors of mechanical stimulation in regulating MSC chondrogenesis, especially the 
mechanotransduction relationship of how physical stimulation is transduced into 
biological signaling, and regulates the intracellular signaling cascades. 
In order to study the modulation of physical forces on chondrogenesis, a proper 
elastomeric scaffold, with desirable mechanical properties, including good recovery 
ratio, is required to support cellular functioning and tissue formation under the 
dynamic mechanical stimulation. A 3D porous poly L-lactide-co-e-caprolactone 
(PLCL) scaffold that has been previously shown to possess characteristics of 
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biocompatibility and elasticity, and supports chondrocytetissue formation, was 
employed as the scaffold platform for this study. Subsequently, dynamic mechanical 
stimulation would be employed on the stepwise updated PLCL scaffold with MSC 
seeding. Themechanisms involved in compression-driven chondrogenic reinforcement 
and hypertrophic abatement would be explored. With the better understanding of 
mechanotransduction, a further stratified PLCL scaffold would be subjected to 
dynamic dual-axis loading. As the scaffold was characterized, the effect of complex 
compression plus shearing loading on the constructs would be investigated in aspects 
of chondrogenesis and ECM zonal distribution. 
 
1.1 Objectives 
To summarize, following gaps exist in mechano-induced chondrogenesis: 
 Uniform scaffold, e.g. hydrogel and synthetic solid polymer, is unable to meet 
with the requirements of elasticity and mechanical strength. 
 Hypertrophy is an inevitable stage inMSC chondrogenesis. However the tissue 
development from hypertrophic chondrocytes is functionally inferior to native 
articular cartilage. 
 Mechanotransduction ispartially understood. The existing reportsonly 
provided limited and incomplete explanation of how physical force is 
translated into biochemical signals. 
 The application of bilayered porous PLCL/chitosan scaffold to compression 
and shearing combined mechanical induced chondrogenesis are scarcely 
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reported. Besides, the effect of this dual-axis mechano-stimulation has been 
insufficiently characterized. 
 
In this thesis, the objectives of the study are as follow: 
 To fabricate and modify porous PLCL scaffold with elasticity and mechanical 
strength, which is desirable for dynamic compression and shearing test; 
 To investigate the cell morphology, cytoskeleton arrangement, chondrogenic 
differentiation and zonal phenotypes in the constructs under mechanical 
stimulations, i.e. deferral dynamic compression and dual-axis loading; 
 To understand how dynamic compression mediates chondrogenesis through a 
biological mechanism study on TGF-β/Smad and integrin β1 signaling, and to 







2. Literature Review 
2.1 Articular Cartilage 
Articular cartilage is a connective tissue that covers the ends of the bones in joints. 
It is devoid of nerves and blood vessels. This simple structured tissue, however, 
provides lubricating and frictionless motion for articulation. This section introduces 
the basic structure and function of articular cartilage, followed by the description of 
cartilage damage, in order to elicit the discussion of current and prospective treatment 
strategies. 
 
2.1.1Articular Cartilage Structure, Composition and Function 
Articular cartilage is a resilient tissue with the function of wear resistance and 
load bearing to facilitate smooth joint motions(Sophia Fox, Bedi, & Rodeo, 2009). It 
also refers to hyaline cartilage because of the pearly translucent color. Articular 
cartilage has a hierarchical structure, and the thickness ranges from 2 to 4 mm in 
humans (Adam et al., 1998 ). It is composed of an extracellular matrix (ECM) with a 
sparse distribution of highly specialized cells called chondrocytes. The ECM exhibits 
a biphasic property with approximately 80% fluid phase and 20% solid phase. The 
fluid is composed of 80% water, and the rest consists of 10%–15% collagen (mainly 
collagen type II (COL II)), 5%–10% cartilage-specific proteoglycans (PGs) – 
aggrecan (AGCAN) with their highly sulfated glycoaminoglycans (sGAG), and other 
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minor collagen types and glycoproteins (Hayes et al., 2007). 
According to the organization of solid components and distribution of 
chondrocytes, articular cartilage is further characterized into four zones: superficial 
zone, middle zone, deep zone and calcified zone (Fig 1) (Aigner and Stove, 2003, 
Coates and Fisher,2010, Keeney et al., 2011, Little et al., 2011).  
 
 
Fig 1. Schematic diagram illustrating the cross-section of healthy articular cartilage. Adapted from A.S. 
Fox et al. 2009. 
 
The superficial zone makes up 10% to 20% of the thickness. It contains the 
highest collagen content, about 85% by dry weight and lowest quantity of PGs. 
Collagen fibers are tightly aligned parallel to the joint surface. Specific proteins such 
as proteoglycan-4 (PRG4) and clusterin are found in this zone (Fig 2). The flattened 
chondrocytes are distributed in close proximity.  
The middle zone occupies 40% to 60% of the total cartilage volume. Unlike the 
superficial zone, it is constituted by higher PGs and glycosaminoglycans (sGAG). The 
COL II fibers are loose and randomly organized into archetypal scaffold. Collagen 
type IX (COL IX), cartilage oligomeric matrix protein (COMP) and cartilage 
intermediate layer protein (CILP) are unique in the middle zone matrix. The 
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chondrocytes are spherical and sparsely distributed at low density. 
 
 
Fig 2. Cartilage zonal distribution of matrix constituents . Adapted from A. Hayes et al. 2007. 
 
The deep zone makes up approximately 30% to 40% of articular cartilage volume. 
It deposits highest sGAG and PGs. The collagen fibrils are arranged perpendicular to 
the articular surface. The chondrocytes are featured to be spherical and aligned in 
columns. Decorin is a specific matrix protein in deep zone. 
The tide mark distinguishes the deep zone from the calcified zone. The calcified 
zone plays an integral role in securing the cartilage to bone, by anchoring the collagen 
fibrils of the deep zone through the tidemark to subchondral bone. The cell population 
is scarce and chondrocytes are hypertrophic and larger in volume. Collagen type X 
(COL X) is highly expressed in calcified zone. 
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In each zone, according to the distance to cells, the ECM matrix can be divided 
into three regions: pericellular, territorial, and interterritorial regions (Bobick, Chen, 
Le, & Tuan, 2009). The pericellular matrix is the closest region to the chondrocyte in 
a distance of 2μm. The collagen fibrils are chiseled. The region is rich in collagen 
type VI (COL VI) and decorin. The territorial matrix lies2-5μm from the chondrocyte 
and is characterized by the archetypal COL II fibrils and the large bottlebrush-shaped 
AGCAN. The interterritorial matrix compartment represents the region more than 
5μm away from the chondrocyte and contains banded COL II fibrils plus a reduced 
content of AGCAN, compared with the pericellular and territorial matrices. 
Overall, the biphasic and zonal structure of articular cartilage contribute to its 
unique biomechanical functions discussed below. 
 
2.1.2 Mechanical Properties of Articular Cartilage 
The mechanical properties of articular cartilage display a depth-dependent 
viscoelasticity (Hayes & Mockros, 1971). It includes unique responses to frictional, 
compressive, shear and tensile loading (Fig 3). Due to the biphasic nature, 
compressive resilience is characterized by the negative electrostatic repulsion forces 
provided from the highly charged sGAG aggregated PGs that attract interstitial 
fluid(Sophia Fox et al., 2009). The PGs, embedding within the solid phase of the 
collagen fibrils that provide the tensile strength, reduces the permeability of articular 
cartilage so as to prevent the interstitial fluid from being readily squeezed out of the 
matrix when loading is imposed and removed.  
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According to the depth-dependent viscoelastic feature, articular cartilage tends to 
stiffen with increased strain, and it cannot be described by a single Young’s modulus. 
The ranges of mechanical properties in tensile, compression and shear are listed in the 
following table: 
Table 1. Biomechanical properties of healthy human articular cartilage 
Mechanical properties Natural human articular cartilage(MPa) 
Tensile Young’s modulus  5–25 
Compression Young’s modulus  0.24–0.85 
Complex Shear modulus  0.2–2.0 
Adapted from Z. Izadifar et al. 2012. 
 
Thezonal organization enables articular cartilage to withstand different types of 
loadings(Mow, Holmes, & Lai, 1984). According to the distinct distribution and 
cross-linking of collagen fibers, and the concentration of PGs and GAGs. The 
superficial zone protects joint from tensile forces because of the parallel-oriented 
collagen despite articular cartilage barely experiences tension. The middle zone 
provides better compressive resilience and excellent resistance to shearing force 
owing to the rising water content entrapped by the high PG contents within the 
randomly distributed collagen fibrils. With the highest deposition of PGs and 
perpendicular collagen fibrils, the deep zone provides greatest resistance to 
compressive forces. In general, the amount, organization and crosslinking of collagen 
fibers determine tension and shear modulus of cartilage while compressive resilience 





Fig 3. Depth-dependent loading exerted on articular cartilage. Adapted from J. M. Mansour, chapter 5. 
 
 
Fig 4. Correlation of compressive stiffness with the total glycosaminoglycan concentration. Adapted from 
J. M. Mansour, chapter 5. 
 
2.1.3 Articular Cartilage Damage 
Damage to articular cartilage can occur from trauma, disease, aging or excessive 
mechanical loading. Cartilage lesions can be classified into three main types: 
superficial matrix disruption, partial thickness defects and full thickness defects 
(Matsiko, Levingstone, & O'Brien, 2013). Superficial matrix disruption results from 
blunt trauma whereby the ECM is damaged, but viable chondrocytes aggregate into 
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clusters and new matrix are synthesized. Partial thickness defects disrupt the cartilage 
surface but do not involve subchondral bone. These defects are unable to self-repair 
unlike superficial matrix disruption because mesenchymal progenitors from the 
marrow are unable to migrate to the injury site. Full thickness defects involve both 
cartilage and subchondral bone. These defects theoretically can elicit a repair response 
due to access to the bone marrow mesenchymal stem cells and cytokines. However, 
the neo tissue generated is known to be fibrocartilage instead of hyaline cartilage. 
This type of cartilage displays poor mechanical strength and durability, and is prone 
to degeneration and osteoarthritis (OA) (Buckwalter & Mankin, 1998, Hunziker, 
2002). 
Due to the limited self-regenerative capacity of articular cartilage, various clinical 
and cellular approaches have been explored which will be introduced in the following 
sections. 
 
2.2 Current Clinical Cartilage Repair Strategies and Limitations 
Articular cartilage defects are classified according to their depth and width. The 
choice of a clinical repair technique depends largely on this classification of the 
defects and whether the lesion requires a palliative, reparative or restorative approach. 
A palliative method includes debridement and lavage (LaPorta et al., 2012). Both of 
the techniques are suitable for the defects of less than 2 cm2. They are often 
considered to be pain relief and improvement of post-operative mobility although no 
functional tissue restoration occurs (Siparsky et al., 2007). Microfracture is described 
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as reparativestrategies(Steadmanet al. 2002). Microfracture involves drilling holes of 
approximately 0.5–1 mm diameter through the articular cartilage tissue and into the 
bone marrow cavity to allow the progenitor cells recruitment to the defect site. It can 
be adopted to the lesions of less than 2–3 cm2. In short term, microfracture has been 
shown to create functional improvement. However, medium to long term follow up 
studies have revealed limited hyaline-like cartilage tissue formation. Restorative 
techniques include mosaicplasty autografts/allografts and autologous chondrocyte 
implantation (ACI) (Gomoll et al., 2010, Hui et al., 2012). Mosaicplasty approaches 
are applied to large lesions with more than 2 cm in diameter. The defects are treated 
by transferring non-weight bearing cartilage tissue to the defect site. The major 
strength is to shorten rehabilitation duration with the implantation of mature intact 
tissues. However, the main limitation of this procedure is donor site morbidity and 
limited lateral integration both within transplanted tissue and between transplanted 
and host tissues(Hui et al., 2012, LaPortaet al., 2012).  
In ACI, healthy cartilage tissues are isolated from non-weight bearing regions of 
a joint, followed by chondrocyte isolation and expansion in vitro. The expanded cells 
are then transplanted to the defect and covered with a sutured periosteal flap. ACI has 
been used in clinical management of full thickness chondral defects for decades 
(Brittberg et al., 1994). It is suitable for the defect in 2–10 cm2. The technique was 
later modified by replacing periosteal cover with collagen membrane and the 
inclusion of a matrix that delivered the expanded cells at the defect site 
(matrix-induced autologous chondrocyte implantation, MACI)(Muller-Rath et al., 
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2007, Zheng et al., 2007). These two upgrades avoid hypertrophy and cell 
dedifferentiation, but donor site morbidity and fibrocartilage formation are still 
inevitable drawbacks. Thus, mesenchymal stem cell (MSC) as an alternative cell 
source is worth exploring for improving cartilage regenerative outcome. 
 
2.3 Cartilage Tissue Engineering 
The poor long-term outcome of conventional treatment methods used clinically 
demonstrates that there still remains an inherent need for alternative approaches in 
cartilage defect repair. Tissue engineering has shown promise in the repair of defects 
within cartilage tissue. In the following sections, an elaboration on cell sources, in 
particular that of stem cells, and the biomaterials, for cartilage tissue engineering will 
be addressed. 
 
2.3.1 Stem cell based Approaches for Cartilage Tissue Engineering 
The aforementioned weaknesses of conventional clinical treatments and 
chondrocyte based approaches encourage the investigation on stem cells with 
chondrogenic potential for articular cartilage repair. Both pluripotent and multipotent 
stem cells have been reported for studying cartilage repair(Hwang et al., 2006, 
Medvedev et al., 2010,Yamanaka, 2009). Multipotent cells primarily refer to MSCs 
from various tissue and structure. The common autologous sources include bone 
marrow (BMSC), umbilical cord blood, synovium, adipose tissue (ADSC) and even 
mobilized peripheral blood (Gnecchi & Melo, 2009; Lee et al., 2004; Mizuno, Tobita, 
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& Uysal, 2012). Bone marrow, umbilical cord blood and synovium derived MSCs is 
reported to possess better chondrogenic potential than adipose derived and peripheral 
blood progenitor cells (PBPCs). However, in vitro and ex vivo studies on umbilical 
cord blood and synovium were less extensively studied than those on bone marrow. 
Furthermore, synovial cells are reported to maintain fibroblastic after chondrogenic 
induction. Most comparative studies on BMSCs versus ADSCs, BMSCs versus 
PBPCs and BMSCs versus ACI showed superior or at least comparable chondrogenic 
outcome from BMSCs treatment. 
Pluripotent cells utilized in cartilage tissue engineering include embryonic stem 
cells (ESCs) and induced pluripotent stem cells (iPSCs) (Medvedev et al., 
2010,Oldershaw et al., 2010,Yamanaka, 2009).They are described to retain the 
differentiating potential even with infinite expansion. However, the safety of 
pluripotent cells application is always the major concern because of ethical issues in 
ESCs and tumorigenicity and viral vectors in iPSCs. 
Thus, the mainstream approach for stem cell based cartilage tissue engineering is 
predominantly onthe use of MSCs. Among all the multipotent cell sources, bone 
marrow-derived MSCs are the optimal choice due to their autologous availability and 
efficient chondrogenic differentiation potential profile. 
 
2.3.1.1MSC Chondrogenesis 
MSC undergo differentiation to form cartilage in a process called chondrogenesis, 
which resemble endochondral ossification during skeletal development (Goldring et 
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al., 2006; Las Heras et al., 2012). The process of chondrogenesis occurs in stages, 
beginning with the aggregation of chondro-progenitor mesenchymal cells into 
precartilage condensations (Fig 5). Cellular condensation is dependent upon signals 
initiated by cell–cell and cell–matrix interactions and is associated with increased cell 
adhesion, formation of gap junctions and changes in the cytoskeletal architecture 
(Stains & Civitelli, 2005).  ECM molecules interact with the cell adhesion molecules 
activate intracellular signaling pathways to initiate the transition from 
chondro-progenitor cells to a fully committed chondrocyte with the secretion of 
specific cartilaginous matrix protein. The highly specialized chondrocytes may remain 
as proliferative, or further develop into hypertrophic cells, with matrix proteins 
replaced by calcification-related molecules, such as alkaline phosphatase (ALP) and 
matrix metalloproteinase 13 (MMP13) (Mackie, Ahmed, Tatarczuch, Chen, & 
Mirams, 2008).  
The hierarchy and regulation of chondrogenic process is precisely controlled by 
cytokines, transcriptional factors, cell-cell and cell-matrix interactions (DeLise, 
Fischer, & Tuan, 2000). Sox9 is the major transcription factor to be expressed as the 
chondroblasts begin condensation. Sox9 directly regulates expression of major matrix 
proteins - COL II and aggrecan (AGCAN). It is also required for the expression of 
minor matrix protein, including collagen type XI (COL XI). During the transition from 
condensation to proliferation, cells continue expressing Sox9 in order to secret more 
COL II and AGCAN. Afterwards, chondrocytes enter proliferative, pre-hypertrophic 
stage with the up-regulation of collagen type XI (COL IX) and COMP. Chondrocytes 
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then enter hypertrophic stage, involving down-regulation of COL II and upregulation 
of collage type X (COL X), alkaline phosphatase (ALP), Runt-related transcription 
factor 2 (RUNX2) and MMP13, leading to endochondral ossification.  
 
Fig 5. Involvement of biomolecules in the process of MSC chondrogenesis. Adapted from I. Gadjanski et 
al. 2011 
 
Throughout the process, chondrogenesis is mediated by a tightly orchestrated 
spatial and temporal presence of growth factors and bioactive factors, including 
parathyroid hormone related protein (PTHrP), Indian hedgehog (Ihh), Wnt, fibroblast 
growth factor (FGF), bone morphogenetic protein (BMP) and transforming growth 
factor-beta (TGF-β) (Gadjanski, Spiller, & Vunjak-Novakovic, 2012). Further 
discussion on these cytokines and their biochemical transduction will be elucidated in 
the sections of growth factor selection and signaling pathways. 
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2.3.1.2 Growth Factors Selection in Cellular Approaches 
Growth factors have been shown to be one of essential supplements in order to 
enhance MSCs proliferation and chondrogenic differentiation. Verified effective 
growth factors include TGF-β1, β2, and β3, BMPs-2, 4, 6, 7, and 9, FGF2, IGF1 
(Kock et al., 2012, Puetzer et al., 2010, Varga et al., 2012) and GDF 5. TGF-β3, 
BMP2, IGF1 and FGF2 are known to enhance proliferation of differentiating MSCs 
(Varga et al., 2012, Kock et al., 2012), while BMP7 is known to enhance ECM 
maturation (Varga et al., 2012). Besides, TGF-β1, BMP2 are known to down-regulate 
the fibrocartilaginous marker COL I. In addition, a combination of TGF-β1 and 
BMP-7 has been reported to enhance ECM formation, but hinder cell proliferation 
(Varga et al., 2012). In our study, the adopted chondrogenic differentiation cocktail 
has TGF-β3 supplementation, with high glucose DMEM media, supplemented with 
ITS premix (containing insulin, human transferrin, and selenous acid), ascorbate, 
proline and antibiotics. 
 
2.3.1.3 Signaling Pathways for Cartilage Repair 
Since chondrogenic process is precisely regulated by growth factors, several 
signaling pathways have been found to participate in programming the fate of cell 
differentiation. The network of regulation covers TGF-β/SMAD, hypoxia-inducible 
factors (HIF), Wnt/β-catenin, nuclear factor kappa B (NF-κB), mitogen-activated 
protein kinase (MAPK) and Indian hedgehog (Ihh) cascades.  
The TGF-β/SMAD signaling has been established as a dominance in cartilage 
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development and maintenance (Wang, Rigueur D Fau - Lyons, & Lyons, 2014). It is 
divided into two distinct branches, the TGF-β/Activin/Nodal branch and BMP/GDP 
branch (Massague, 2000; Schmierer & Hill, 2007). The activation of the signaling is 
through TGF-β and BMP ligands, binding specific type II receptor which then 
engages the type I receptors (Fig 6). These receptors are called activin-like kinase 1 
(ALK). Engagement of ALK5 in TGF-β/Activin/Nodal branch resulted in the 
phosphorylation of the downstream transcription factors SMAD2 and SMAD3 in 
TGF-β/Activin/Nodal branch (Kopesky et al., 2011), while ALK1 in BMP/GDP 
branch activates SMAD1, SMAD5 and SMAD8 (Hellingman et al., 2011). Evidence 
suggests that TGF-β/Activin/Nodal branch contributes to the maintenance of the 
stable quiescent phase of chondrocytes and the induction of AGCAN and COLII 
production. Conversely, BMP/GDP branch has been reported to stimulate 
hypertrophic differentiation. The participation of TGF-β/SMAD signaling and other 




Fig 6. Schematic diagram of signal transduction by TGF-β/SMAD family. P. Dijke and H. M. Arthur, 2007. 
 
HIF is a transcription factor highly induced in hypoxia differentiation of MSC 
(Gelse et al., 2008), and knock-down study has confirmed its essential role for 
hypoxic induction of chondrogenesis (Duval et al., 2012). It is also reported to 
contribute to the maintenance of ECM homeostasis, inducing the gene expression of 
two main matrix components: COLII and AGCAN. HIF is also implicated in the 
hypoxia suppression of hypertrophy (Gawlitta, van Rijen, Schrijver, Alblas, & Dhert, 
2012), possibly by preventing Runx2 binding to promoter region of the ColX (Duval 
et al., 2012). HIF involvement in the regulation of angiogenetic factor - vascular 
endothelial growth factor (VEGF) expression, modulates an essential step in 
endochondral bone formation (Forsythe et al., 1996).  
Wnt pathway mostly refers to canonical β-Catenin-dependent cascade. The 
signaling is transduced by translocating β-catenin into nuclear and then mediating 
transcriptional activity. The involvement of canonical Wnt pathway in the process of 
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chondrogenic differentiation is complex, and it participates throughout the initiation 
of chondrogenesis to the hypertrophic maturation. The inhibiting effect on embryonic 
mesenchymal cells condensation and cartilage nodules transition was reported when 
ligands of β-catenin were forced to express(Church, Nohno, Linker, Marcelle, & 
Francis-West, 2002). By contrast, β-catenin was shown to promote chondrocyte 
differentiation in a Sox9-dependent manner(Yano et al., 2005). In addition, canonical 
Wnt pathway commonly cross-talks with other signaling pathways in modulating 
chondrogenesis. Wnt3A was reported to enhance BMP2-mediated chondrogenesis of 
murine mesenchymal cells (Fischer, Boland, & Tuan, 2002); and in adult human 
marrow stromal cells, TGF-β induced chondrogenic differentiation could be promoted 
through β-catenin activation(Tuli et al., 2003). Furthermore, during endochondral 
ossification, canonical Wnt pathway was shown to play a crucial role in the 
chondrocytes hypertrophic maturation (Dong, Soung do, Schwarz, O'Keefe, & Drissi, 
2006). 
The MAPK pathway is known to control the conversion of a vast number of 
extracellular stimuli into specific cellular responses (Zarubin & Han, 2005). MAPKs 
are categorized into three distinct classes in mammals: the extracellular 
signal-regulated kinases (ERK1/2), the c-jun N-terminal kinase (JNK) and p38. 
Studies have shown that ERK1/2 and p38 function in a reciprocal bidirectional 
equilibrium and alter expression of MMP3, MMP13 and COL II (Bobick & Kulyk, 
2008). The production of MMPs was reported to dependent on ERK1/2 
phosphorylation. MAPKs also interact closely with other pathways such as 
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TGF-β/SMAD and integrin signaling.  
Ihh/PTHrP negative feedback loop is a well-established regulator that controls the 
proliferative zone of the growth plate and the role of PTHrP in preventing 
differentiated chondrocytes from entering hypertrophy phase has been well 
established (Kronenberg & Chung, 2001). 
Other signaling pathways like NF-κB were also studied in cartilage formation. 
NF-κB transcription factors are a family of ubiquitously expressed molecules that 
regulate a wide range of immune responses, cellular growth, differentiation and 
survival (Oeckinghaus & Ghosh, 2009). In chondrogenesis, activated NF-κB regulates 
the expression of several matrix degrading enzymes, including MMPs, thus 
influencing the amount and remodeling of ECM proteins, and shows indirect positive 
effects on downstream regulators of terminal chondrocyte differentiation such as 
β-catenin and RUNX2 (Rigoglou & Papavassiliou, 2013). A further detailed 
discussion on hypertrophic development and chondrogenic termination would be 
expanded in the next section. 
 
2.3.1.4 Hypertrophic Development in Chondrogenesis 
Hypertrophy is an inevitable progression of MSCs chondrogenesis in vitro 
(Mueller & Tuan, 2008; Schatti, Grad S Fau - Goldhahn, et al., 2011). The 
progression to hypertrophic phenotype is thus one of the concerns for clinical 
application of MSCs in articular cartilage repair due to the inferior biological and 
mechanical functions of hypertrophic cartilage. Hypertrophy can be evaluated by 
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markers: RUNX2, MMP13, COL X and ALP. ALP excessively exists in bone, and is 
applied as an indicator of terminating chondrogenesis (Habuchi, Conrad, & Glaser, 
1985). COL X is a well-known hypertrophic chodrocyte-specific ECM component 
(Aigner et al., 1997). It was shown that Collagen alpha-1(X) gene (COL10A1) is the 
direct transcriptional target of RUNX2 (Zheng et al., 2003 )(Nishimura et al., 2012). 
Additionally, RUNX2 regulates osteoblast-specific transcription factor Osterix (Osx), 
and it further activates the expression of MMP13 (Zhang, Tang, & Li, 2012) whose 
protein is efficient at cleaving COL II (Billinghurst et al., 1997). RUNX2 as a distinct 
marker for hypertrophic chondrocytes transition also participates in BMP/GDP branch 
in TGF-β/SMAD signaling (Fig 7). It interacts with SMAD1 and forms 
RUNX2-SMAD transcriptional regulatory complexes which are essential for 
chondrocyte hypertrophy and ossification (Javed et al., 2008). Signaling pathways 
that either enhance or suppress chondrogenic hypertrophy include TGF-β/SMAD, 
Wnt/β-Catenin, Indian hedgehog (Ihh) and integrin. Despite relatively comprehensive 
studies on TGF-β/SMAD2/3 branch, Wnt/β-Catenin pathway and Ihh/PTHrP negative 
feedback loop, integrin pathway has been poorly understood in the regulation of 
chondrocyte hypertrophy, with limited evidence of involvement of β1 subunit and 
cross-talk with RhoA/Rock in MAPK signaling. Moreover, inadequate research on the 
interaction between TGF-β/BMP branches leaves an incomplete understanding of 
chondrogenic hypertrophy. 
 Fig 7. Schematic diagram of molecular pathways of chondrocyte hypertrophy. Adapted from D. Studer 
al. 2012. 
 
2.3.2 Mechanotransduction in Cartilage
There has been a growing interest in understanding the mechanotransduction 
mechanism of how physical stimulation is transduced into biological signaling, and 
regulates the intracellular signaling cascades. The process of cells responding 
appropriately to applied mechanical forces can be divided into four phases: (i) 
ECM-coupling - when the altered extracellular environment interacts with the effect 
or and sensor cells; (ii) mechano
sensor cell detect the deformation of ECM; (iii) transmembranal
the forces are transduced from the outside of the sensor cell into biochemical signals 
within the cell; (iv) signal transmission from the sensor to the effect or cells, for 
example from mature chondrocytes to chondroblasts.
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Thus, the key of mechanotransduction responses is the sensory proteins and 
mechanoreceptors, such as stretch-activated ion channels, annexin V and integrin as 
reported (Lucic, Mollenhauer, Katherine, Kilpatrick, & Cole, 2003; Mobasheri, Carter, 
Martin-Vasallo, & Shakibaei, 2002). Stretch-activated ion channels have been shown 
to detect multiple mechanical forces including vibration, pressure, stretch, touch, etc. 
It is mainly expressed in neuron’s plasma membrane though transient receptor 
potential vanilloid 4 (TRPV4), belonging to one of its superfamily, which has been 
recently detected in porcine articular chondrocytes. Annexin V is a cell surface 
receptor binding to COL II. The collagen/annexin V interactions has been reported to 
play a regulatory role in terminal differentiation and mineralization events of growth 
plate chondrocytes and apoptosis due to static stress.  
Integrin is of particular interest for it binds to ECM proteins (collagen and 
fibronectin) (Halper & Kjaer, 2014). Integrin signaling is complex in that it interacts 
with other pathways to form a huge network which mediates many cellular processes, 
such as migration, growth and differentiation (Giancotti, 1999; Harburger & 
Calderwood, 2009). Among integrin-dependent signal cascade, FAK is an essential 
downstream enzyme that regulates cell migration, activation of Rho family of GTPase 
and crosstalk between growth-factor signaling (Millward-Sadler & Salter, 2004). By 
the activation of Rho GTPase, mitogen-activated protein kinase (MAPK)/ERK 
cascade is connected with the regulation of integrin β signaling (Saleem et al., 2009). 
Chondrocytes have been found to predominantly express β1 subunits (Aszodi, 
Hunziker, Brakebusch, & Fassler, 2003). Along with binding α subunits, the β1 
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subunits serve as receptors for collagen which bridges cellular cytoskeletal interaction 
with ECM components. Formation of stress fiber, along with activation of integrin β1, 
FAK and ERK was involved in tension stretch-mediated inhibition of chondrogenesis 
(Takahashi, 2003), highlighting the role of integrin/FAK/ERK signaling axis in 
mediating external physical stimulation. 
 
2.3.3 Biomaterials for Cartilage Tissue Engineering 
The choice of materials considered in scaffold design is based on several criteria: 
biocompatibility, mechanical strength, cell affinity, adjustable biodegradability and 
ability to promote cartilage tissue formation. Technologies nowadays are capable of 
realizing one or more applications of above features in a single scaffold. The materials 
used in cartilage tissue engineering can be roughly grouped into two categories: 
natural-component and polyester-based scaffolds. These two types possess unique 
advantages but also have their own shortcomings which will be addressed in the 
following sections. 
 
2.3.3.1 Natural Materials and Hydrogels 
Natural materials used in cartilage tissue engineering are either the components 
of ECM such as collagen, chondroitin sulfate (CS) and hyaluronic acid (HA), or other 
natural polymers like alginate, agarose, chitosan and silk fibroin. The scaffolds made 
of natural materials are mainly in the form of hydrogels. Hydrogels are a network of 
hydrophilic polymer chains. Because they physically resemble the soft tissue, 
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considerable in vitro and in vivo studies have been conducted on them. The 
homogenously suspended cells in natural polymer hydrogels like chitosan, collagen 
and hyaluronic based scaffold tend to maintain rounded morphology which may 
induce chondrocyte phenotype. Additionally, poly ethylene-glycol (PEG) based 
hydrogels as one of synthetic hydrogels have been broadly studied because of a wide 
range of crosslinker choices. Biomolecules like CS, HA, COL I, COL II and RDG 
peptides have been linked to PEG hydrogels in order to facilitate cell attachment and 
ECM deposition. However, although mechanical properties of hydrogels can be 
modified by altering crosslinking density, the limited range of mechanical strength is 
still the major drawback (Bryant & Anseth, 2002). 
 
2.3.3.2 Polyester-based Synthetic Scaffolds 
Polyester-based scaffolds are created from synthetic and biocompatible polymers. 
Although the main drawback of polyester-based synthetic materials is that their 
degradative products are acidic which might result in local inflammation and cell 
death, the benefits of using these materials for cartilage tissue engineering include 
biodegradability, structural malleability and controllable mechanical 
properties(Moutos & Guilak, 2008). They can be fabricated into a range of different 
forms, such as particles, meshes and fibers, to cater to the demand of cytokine 
delivery and cell behavior control. The most commonly applied polyesters 
polycaprolactone (PCL), polylactic acid (PLA), polyglycolic acid (PGA) 
andpolylactic-co-glycolic acid (PLGA) are all Food and Drug Administration (FDA) 
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approved. However, despite the advantages above, polyester-based scaffolds have 
been shown low affinity for cell adhesion. For example, PLA is hydrophobic due to 
the additional methyl group (Oh, 2011). The strategies to improve cell attachment and 
permeability are to blend or crosslink with hydrophilic materials or cell-ECM 
interacting molecules, for example chitosan, polymethacrylic acid, fibronectin and 
chondroitin sulfate molecules.  
 
2.3.3.3 Elastomeric Polymer 
Another concern of selecting appropriate polyester scaffold relates to the 
biomechanics of articular cartilage. By simply increasing the modulus of polyester 
materials hardly reflect the unique viscoelastic feature of the cartilage. Achieving a 
combination of strength and elasticity has been a particular challenge if only single 
polyester is used. Lactides are of excellent choice due to high elastic modulus, 
whereas itshigh glass transition temperature and crystallinity result in a low 
degradation rate. This disadvantage of PLA may be overcome by blending or 
copolymerizing with other lower glass-transition temperature cyclic esters, such as 
PCL(Fernandez, Etxeberria, & Sarasua, 2012). ε-Caprolactone is a seven membered 
ring with five methylene groups, which provides increased flexibility to the main 




Fig 8. Equation of the synthesis of PLCL statistical copolymers.Adapted from J. Fernández et al. 2012. 
 
Thus, a co-polymer, poly(L-lactide-co-ε-caprolactone) (PLCL) constitutes a 
synthetic scaffold (Fig 8) with suitable elastomeric and biodegradable characteristics 
for cartilage tissue engineering. 
 
2.3.3.4 Stratified Scaffolds  
The distinctive mechanical properties of articular cartilage can be attributed to the 
zonal organization and distinctive ECM composition arrangement. One problem of 
current cartilage tissue engineering is the absence of such sophistication which results 
in repair cartilage of inferior mechanical functionality, even though there is 
substantial ECM deposition and cell distribution. Hence, researchers have attempted 
to replicate this zonal structure in scaffold design, by creating stratified variations to 
induce comparable tissue formation. The stratified scaffolds applied in cartilage tissue 
engineering introduced in this thesis mainly refer to scaffold design with structural or 
biochemical variation. 
The biochemically stratified scaffolds refer to the various content or percentage 
of biomaterials or matrix molecules among layers. Different polyesters within the 
stratified scaffolds display multiple advanced mechanical properties in tension, 
compression, shear or a combination of the formers (Ng et al., 2006), while varying 
the incorporation of matrix molecules such as collagen, hyaluronan, CS, 
metalloproteinase, in different layers can mimic the articular ECM organization. A 
zonal PEG hydrogel fromNguyen et al., 2011 was proved toinduce MSCs into 
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zone-specific chondrocytes and promote zone-specific chondrogenesis similar to 
natural cartilage (Nguyen, Kudva, Guckert, Linse, & Roy, 2011). However, the 
hydrogels were prepared separately and then assembled to make a multilayer scaffold. 
One major limitation of this approach is the possible delamination of distinct layers 
when exposed to shearing stress. It is necessary to develop particular fabricating 
techniques and strategies for stratified scaffold to enhance the integration of the layer 
interfaces. Alternatively, to upgrade the stratified scaffold into a continuous 
composite material such as those demonstrated in Fig 9. 
 
Fig 9. Schematic diagram of designing development of stratified scaffold for cartilage tissue engineering. 
Adapted from N. H. Dormer 2010. 
 
The structural variations primarily include fiber orientation, pore size and a 
combination of the formers (Fig 10). Employing sequential electrospinning technology, 
a depth-dependent microstructural trilaminar scaffolds was fabricated with varying 
fiber size and orientation in a continuous construct, resulting in the formation of tissue 
mimicking some organizational characteristics of native cartilage(McCullen, Autefage, 
Callanan, Gentleman, & Stevens, 2012). In another study, Steele et al., 2012 fabricated 
a bilayer PCL scaffold that consists of aligned microfiber layer deposited on top of the 
macroporous scaffold of varying pore sizes. The structural organization of aligned fibre 
membranes mimicks the cartilage’s superficial zone and act to enhance the mechanical 
and surface properties of the macroporous scaffold. Zonal analysis of these scaffolds 
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demonstrated region-specific variations in chondrocyte number, GAG-rich ECM, and 
chondrocytic gene expression, demonstrating the potential of designing multiphasic 
structural organization for zonal articular cartilage engineering.  
 
Fig 10. Schematic diagram of structural stratified scaffold design. Adapted from McCullen et al. 2012. (A) 
and Steele et al. 2013 (B). 
 
 
2.3.4 Mechanical Stimulation for Cartilage Tissue Engineering 
It has been well-established that mechanical stimulation is crucial to the healthy 
development and maintenance of native articular cartilage. The clinical physical 
rehabilitation of weight bearing and continuous passive motion protocols after ACI or 
MACI highlights the significance of mechanical stimulation for cartilage 
regeneration(Edwards, Ackland, & Ebert, 2014). In natural conditions, human articular 
cartilage experiences compression and shearing with an average deformation of 6% 
strain. The pressure is measured to be 1 MPa while static standing, 0.1 to 4 MPa in 
walking and a peak of 10-20 MPa during stair climbing (Fig 11) (Eckstein et al., 2005).  
 Fig 11. Magnitude of cartilage deformation 
2005. 
 
Various mechanical stimuli including hydrostatic pressure, sliding/rolling 
indentation loading, and static/dynamic tension, compression and shearing forces have 
been explored to enhance the quality of tissue engineered cartilage 
2011).As numerous studies on wide range of amplitudes and frequencies of mechanical 
loading on cartilage tissue engineering for short term and long term have been 
conducted, increasing evidence has shown that mechanical stimulation during MSCs 
chondrogenesis can alter differentiating process, ECM deposition and mechanical 
properties of the cartilage. 
promoting anabolism and catabolism of ECM, and change of chondrocytes phenotype
(Grodzinsky, Levenston, Jin, & Frank, 2000)





with different types of activities. Adapted from F Eckstein 
(Schatti, Grad, et al., 
The alteration is facilitated by increasing fluid flow, 
. However, whether it is an enhancement 





2.3.4.1 Compression and Shearing Stimuli 
2.3.4.1.1 Compression 
Compressive loading has been considerably studied on in vitro cartilage constructs. 
It has been shown that compression can modulate chondrocyte viability, chondrogenic 
gene expression and ECM synthesis. For example, dynamic compression at moderate 
levels (2-10% strain; or 0.5-1.0 MPa) (Wong, Siegrist, & Cao, 1999), physiological 
frequencies (0.01 to 1.0 Hz) (Sah et al., 1989)and long-term manner (~days of 
culture)can stimulate the deposition of collagen and PGs (Parkkinen et al., 1993) and 
increase equilibrium compressive modulus. Short-term or early start of compression 
either resulted in non-significant difference between free swelling culture or loss of 
ECM deposition. 
According to natural in vivo activities, normal paced walking was recorded to be 
±5% strain and 1 Hz per day. In the study using chondrocytes seeded in porous calcium 
phosphate scaffold, these parameters were proved to stimulate a 30% increase in 
proteoglycan content,a 40% increase in collagen content, and a three-fold increase in 
equilibrium modulus during the four week of stimulation (Waldman, Spiteri, Grynpas, 
Pilliar, & Kandel, 2004). 
 
2.3.4.1.2 Shearing  
To isolate the effects of tissue deformation from phenomena related to fluid flow, 
Frank et al. and Jin et al. applied direct shear to cartilage explants. Dynamic shear 
deformation (1-3% strain, 0.01-1.0 Hz) was shown to stimulate collagen and 
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proteoglycan biosynthesis 50% and 25%, respectively. Interestingly, shear loading 
preferentially up-regulated collagen biosynthesis over proteoglycan biosynthesis (2:1), 
whereas dynamic compression leads to a nearly identical up-regulation of collagen and 
proteoglycan biosynthesis for the same bovine cartilage explant system. So far, only 
limited studies directly exploit tissue shear strain to modulate the in vitro development 
of cartilage constructs. Waldman et al. cultured chondrocytes in porous calcium 
phosphate scaffolds for four weeks under free-swelling culture followed by four weeks 
of culture with daily dynamic shear strain. Constructs subjected to six or 30 minutes of 
cyclic shear strain (2% shear strain at 1 Hz, superimposed on a 5% compressive tare 
strain) per day had higher rates of collagen and proteoglycan synthesis. After four 
weeks of daily six minute loadings, loaded constructs contained 40% more collagen 
and 35% more proteoglycan than free-swelling controls. Constructs exposed to shear 
forces also had a significantly higher equilibrium modulus and maximum stress (six- 
and three-fold increases, respectively). These increases over statically-cultured 
constructs are similar to the increases reported for similar constructs under dynamic 
compression. 
 
2.3.4.2 Multi-axial Mechanical Stimuli 
Based on the premise that mechanical factors play an important role in the 
development and maintenance of healthy cartilage in vivo, numerous investigators have 
shown that either dynamic compressive or shear loading of chondrocytes in 3D culture 
stimulate the synthesis of cartilaginous ECM macromolecules. When the stimulus is 
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applied intermittently over a long duration (i.e. several weeks) the cells accumulate 
greater amounts of ECM which also results in the improved mechanical performance of 
the in vitro-formed tissue. Although the application of these relatively simple loading 
conditions has resulted in beneficial effects, articular cartilage in vivo is subjected to 
complex loading consisting of a combination of both compressive and shearing forces 
under normal physiological conditions. This pattern of loading is also important for the 
formation of the non-homogenous structure of cartilage ECM which can create a 
multi-axial stress within the tissue. Some studies have investigated the effect of 
complex loading applied to the engineered through the use of a rotating or rolling ball 
that is compressed against the tissue surface to simulate physiological loading (Grad et 
al., 2005; Stoddart et al., 2006). Although in these experiments multi-axial loads were 
applied to the tissue, they were not well-defined as the applied strains (or stresses), and 
the compressive and shearing forces displayed a nonlinear regime if measured in 
different part of the construct. 
A controllable and quantitative dual-axis mechanical stimulation on cartilage 
formation has been reported. The construct was composed of bovine chondrocytes on a 
porous calcium polyphosphate (CPP) substrate (Waldman, 2007). After a 4-week 
pre-culture, the constructs were subject to another 4-week dual-axis stimulation. More 
ECM with an increase in both collagen (~ 54%) and PGs (~ 46%) and enhanced 
mechanical properties with an average 3-fold increase in compressive modulus and 
a1.75-fold increase in shear modulus were observed in compression-shear stimulated 
constructs. Notwithstanding the positive effect of dual-axis stimulation, CPP is more 
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applicable for bone tissue engineering because it is a major component of bone mineral. 
More suitable materials for cartilage formation should be considered for multi-axis 
mechanical stimulation. 
 
2.3.4.3 Bioreactor Design 
Bioreactors were initially developed to allow the high-mass culture of cells used 
for industrial applications (Martin, Wendt, & Heberer, 2004), but these applications 
have been recently employed to tissue engineering purposes. An eligible bioreactor 
should satisfy one or more criteria below: (i) to facilitate uniform cell distribution; (ii) 
to increase mass transport both by diffusion and convection using mixing systems of 
culture medium; (iii) to expose cells to physical stimuli; (iv) to enable reproducibility, 
control, monitoring and automation. In addition, bioreactors should be designed in 
simple framework in order to prevent contamination. 
Mechanical bioreactors can be classified into confined and unconfined system 
according to the design of chamber. Studies have shown that matrix production was 
increased in both confined and unconfined bioreactor. Confined system refers to a fixed 
compartment for scaffold loading without media circulation. The radial constrain 
avoids free lateral cartilage deformation. The fluids are pressurized depthwise when 
mechanical force is loaded, which makes the stress-strain modulus difficult to 
interpret. Additionally, the technical issue regarding the porous interface for fluid 
permeability is a major obstacle of bioreactor configuration (Buschmann, et al., 1998). 
One alternative is unconfined compression, where a tissue or construct is compressed 
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between two smooth impermeable surfaces. This geometry has been widely used for 
the study of the biological effects of loading (Grodzinsky, et al., 1998).Thus, in order 







3. Materialsand Methods 
 
3.1 Scaffold Fabrication 
3.1.1 PLCL Scaffold  
Porous PLCL scaffold is fabricated by using porogen leaching and lyophilization. 
Briefly, porogens, i.e. sodium chloride, were prepared in large volume. Powder sodium 
chloride (Sigma) was grounded in a mortar, and separated through 200μm and 100μm 
sieves. The porogen size was then examined using a haemocytometer under 
microscope. Porogens in two sizes (250-300μm and 100-150μm in diameter) were 
stored in dry places separately.  
PLCL (LA:CL = 7:3; Mw 23,000 Da; Daigang Biomaterials, Inc.) was dissolved in 
chloroform (10% w/v), mixed with 250-300μm sodium chloride (200% w/v), casted in 
a customized Ø35Χ6mm Teflon mold, compacted and evaporated at ambient 
temperature overnight. Then porogen was leached out in distilled water with daily 
change of water for a week. The resultant dried scaffold has a thickness of 5mm. 
Scaffolds with the size ofØ5Χ5mm cylinder was obtained with a punch, and stored in 
dry places at ambient temperature. 
The preparation of stratified PLCL scaffolds differs from the single layer in that, 
immediately after the first layer of 250-300μm sodium chloride/PLCL scaffold was 
casted (volume used = 4ml), the mixture of PLCL and 100-150μm porogen (volume 
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used = 2ml) was spread on the former scaffolds when the chloroform was not fully 
evaporated at the surface. With the respective volume employed for the two layers, the 
thickness of the small pore layer (~1mm) was half of that of the large pore layer 
(~2mm). The subsequent steps remained the same as described above.   
For the bi-layer stratified PLCL scaffold, the layer with 250-300μm pore size was 
assigned as large pore (LP) layer, while the layer with 100-150μm pore size was 
assigned as small pore (SP) layer. 
 
3.1.2 Chitosan Coating of the PLCL Scaffold 
An aminolysis method was used to immobilize chitosan on the PLCL scaffolds (Li et al, 
2012). The scaffolds were treated with tris-(2-aminoethyl)-amin (10%v/v in 
isopropanol) solution for 15min. Then the scaffolds were washed three times in PBS for 
20min each. They were subsequently activated with 2.5% glutaraldehyde for 1hr, 
followed by a thorough wash in PBS (20min for three times). The scaffolds were then 
incubated with 10 mg/mL chitosan (Guoyao Chemical Reagents Limited) solution 
(Degree of deacetylation 80.0–95.0%; viscosity 50–800mPa∙s; pH=3.5) at ambient 
temperature for 5 hours, then rinsed with 0.1 N acetic acid solution for 3 hours. Finally, 
the scaffolds were washed in distilled water thoroughly for 5 days with daily water 
change. 
 
3.2 Scaffold Characterization 




TGA and FTIR provide a complete sample analysis with quantitative weight loss 
data from TGA and identification of evolved gases by FTIR. This combined analysis 
was used to determine chitosan crosslinking on PLCL scaffolds. Thermogravimetric 
data (Q500, TA instrument) were acquired every10 seconds as the samples were heated 
in the TGA at 20ºC/min from room temperature to 900 ºC under a positive flow of 
nitrogen. Sample sizes were 50 mg, and spectral data (Vertex 70, Bruker) were 
collected from 400 to 4000 cm-1. Spectral searches were done with Sadlter 
SearchMaster software with their vaporphase library and algorithms. 
 
3.2.2 Porosity Measurement 
The exact size of the scaffold was measured with a vernier caliper, and the masses 
of the scaffolds were taken. The scaffolds were then completely immersed in absolute 
alcohol for 2 hr before being weighted again. To prevent variation due to ethanol 
evaporation from the scaffold, scaffolds were only removed from ethanol immersion 
prior to weight measurement. Porosity was calculated as (Ws-Wd)/ρ/V, where ρ 
represented the density of alcohol, V represented the volume of the scaffolds, and Ws 
and Wd represented the weight of wet and dry scaffold, respectively. 
 
3.2.3 Compression analysis and measurement of Recovery Ratio 
An unconfined compression test was carried out with an Instron 5567mechanical 
test instrument. Compressive loads were applied to individual specimen in a PBS bath 
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using a stainless steel indenter. All the samples were pre-loaded three times to a 10% 
strain before a constant loading at a displacement of 0.5 mm/min until 45% strain was 
reached. The thickness of each scaffold was measured to calculate the compressive 
recovery ratio within 1 min after removal of the compressive load. The recovery ratio 
was used to assess the capability of the scaffolds to recover from the deformation and 
expressed as recovery ratio (recovery ratio = L1/L0, where L1 and L0 are the final and 
initial thickness of the scaffolds after and before compression, respectively). 
 
3.2.4Scaffold Characterization- Scanning Electron Microscopy (SEM) 
The scaffolds were pre-air-dried, and post-dried using a critical point dryer, 
mounted and stored in 50ºC oven overnight. Images were taken with a JOEL 1000 
SEM. 
 
3.3 Cell culture and Chondrogenic Differentiation 
3.3.1 MSC Isolation and Culture 
MSCs were collected from bone marrow aspirates of consented human donors, 
after obtaining approval from Institutional Review Board (IRB). The bone marrow 
aspirate was washed three times with HBSS (Invitrogen). Mononuclear cells were 
isolated from the bone marrow aspirates using the RosetteSepTM (STEMCELL 
Technologies, Singapore) kit following the manufacturer protocol. The isolated 
mononuclear cells were cultured in low glucose DMEM (Invitrogen) media 
supplemented with 10% FBS (Invitrogen). After 72-hour incubation at 37°C in 5% CO2, 
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non adherent cells were removed while the adherent MSCs were further cultured. Cells 
were trypsinised by using TrypLETM (LifeTechnologies, Singapore) when reached 
70–80%confluency.The cell number was calculated using Neubauer improved 
haemocytometer. The cell suspension was then centrifuged at 200xg for 5 minutes in 
Hybrid Refrigerated Centrifuge 6200 (Kubota Corporation, Japan), followed by 
resuspension and expansion in new T175 flasks. A homogenous MSC population was 
collected after 1–2 weeks of culture at passage 3-4 when the number of cells was 
sufficient for the experimental set. 
 
3.3.2 Primary Chondrocyte Isolation and Culture 
Chondrocytes were isolated from articular cartilage of mini-pig. Briefly, slices of 
cartilage tissue collected from femoral condyle were digested first with 0.25% TrypLE 
(LifeTechnologies, Singapore) for 30 min, then agitated with 0.25% (w/v) 
type-IIcollagenase solution (LifeTechnologies, Singapore) in DMEM for 12–16 h 
at37°C. Isolated chondrocytes were expanded in low glucose DMEM (Invitrogen) with 
10% FBS in the presence of 1ng/ml TGFβ-3 (R&DSystems, Minneapolis, MN), 2ng/ml 
PDGF (R&D Systems, Minneapolis, MN) and 2 ng/ml of FGF (R&D Systems, 
Minneapolis, MN). Fresh chondrocytes were seeded onto PLCL scaffold and used in 
cytoskeletal organization assessment. 
 
3.3.3 Chondrogenic Differentiation of MSCs in PLCL Scaffold 
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The scaffolds were sterilised by ethylene oxide fumigation before cell seeding. The 
scaffold was surface activated with 70% ethanol, before being immersed in PBS until 
use. Before cell seeding, the scaffold was blotted dry. For single layered scaffolds, 
MSCs (107 cell/mL in density, 30-40 μL in volume) were seeded onto the scaffolds 
immediately, allowed for adhesion for 2 hours at 37°C in 5% CO2. For bi-layered 
scaffolds, MSCs in the same density were seeded onto larger-pore side first allowed 
for1hr adhesion, followed by a seeding and adhesion onto the smaller-pore side. After 
allowing for cell attachment, the constructs were fed with MSC expansion media and 
cultured overnight as, before switching to chondrogenic medium the next day. 
Chondrocytes were only seeded onto the single layered scaffolds, cultured for 1 week 
and used in cytoskeletal organization assessment. 
Chondrogenic differentiation medium contains high glucose DMEM (Invitrogen) 
supplemented with 10-7 M dexamethasone (Sigma-Aldrich), 1%ITS+ premix (BD 
Bioscience Inc.), 50 µg/ml ascorbic acid, 1 mM sodiumpyruvate (Sigma-Aldrich), 4 
mM proline (Sigma-Aldrich) and10 ng/ml of TGF-β3 (R&D Systems, Minneapolis, 
MN).  The medium was changed every 3 days. 
 
3.3.4 Mechanical Stimulation Set Up 
A custom-made, computer-operated mechanical stimulator, provided by our 
collaborator, Prof. Tan Lay Poh (School of Materials Science & Engineering, Nanyang 
Technological University) was used for dynamic stimulation studies (Fig. 12).The 
stimulator system consisted of a pair of push plates between which scaffolds 
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(represented as green object in Fig 12B) were loaded (between the 2 red lines). The 
compression force was generated through relative locomotion (blue arrows) of the 
push plates driven by the motors connected. The scaffold between the push plates 




Fig 12. Schematic diagram (A) and snapshot (B) of the bioreactor. 
 
A free swelling control, in which no mechanical stimulation was applied to the 
scaffold, was set as the control. For free swelling (SF) control group, the constructs 





For deferral dynamic (DC) compression culture, the cell seeded constructs were 
allowed for 3 weeks of chondrogenic differentiation in free swelling condition before 
subjecting to a further 3 weeks of deferral dynamic compression in the same 
chondrogenic media (Fig 13B). “Deferral” was used in this thesis, referring to samples 
subjected to delayed compression after a period of differentiation initiation, to 
distinguish from condition in which compression was applied at the beginning of 
differentiation in other studies (Huang, et al., 2010). Cyclic compressive force was 
loaded on specimens at 5% of strain, 1Hz of frequency and 2 hours per day for 3 weeks. 
For inhibition of activin/nodal/TGF-β signaling, SB431542 (1μM, Sigma, USA) was 
included in the media after 3 weeks of free swelling differentiation, and subjected to 
further 3 weeks of free swelling or deferral dynamic compression conditions. For the 
inhibition of integrin-ECM interaction, BD552828 (0.1μg/mL, BD Biosciences 
Pharmingen, USA) was included in the media after 3 weeks of free swelling 
differentiation and subjected to further 3 weeks of free swelling condition (Fig 13). 
Deferral dynamic dual-axis ((DA) stimulation was performed on bilayered 
constructs. The loading was applied for 3 weeks after a 3-week free swelling culture 
(Fig 13 C). The physical stimulation was composed of 5% of compressive strain and 3% 
shearing strain (Fig 13D). The amplitude and duration remained to be 1Hz of 
frequency and 2 hours per day for 3 weeks. 
The derivation of 3% shearing strain is illustrated as follows: 
In the force analysis (Fig 13D), 
F, is external force 
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A, is the area of contact surface 
σ, is the compressive stress  
τ, is the shear stress 
E, is Elastic Modulus 
G, is Shear Modulus 
ε, is the strain of compression 
γ, is the strain of shearing 
The subscript c represents “compression”, and s stands for “shearing”. 
The external force has components along incline in both upward and downward 
direction. 




















 = 5% 
The relation between elastic constants, i.e. Elastic modulus E and shear modulus 
G, is E = 2G (1 + ν). ν is Poisson's ratio. Most polymers exhibit Poisson ratio values 










 = 2 ε(1+ ν) tan15° ≈ 3% 




Fig 13. Schematic diagram of the experimental designs of(A) free swelling,(B) deferral dynamic 
compression, and (C) dynamic dual-axis loading conditions were shown. (D) shows that the principle of 
dual-axis loading is based on force decomposition into perpendicular directions. 
 
The study comparing cartilage formation on either LP or SP layer subjected to 
shearing force was conducted before the effect of dual-axis physical stimulation was 
investigated. When shearing was loaded on the LP layer, the constructs underwent a 
complete collapse due to the long-term deformation exerted on the LP layers. Thus for 
subsequent experiment with dual-axis physical stimulation using the bi-layer scaffold, 




3.4 Assessment of Cell Attachment- Scanning Electron Microscopy (SEM) 
Cell attachment on scaffold was analyzed by SEM. Briefly, samples were fixed by 
paraformaldehyde overnight and post-fixed by 1 % buffered osmium tetroxide for 1hr. 
Then, the samples were dehydrated through 50%, 75%, 95%, and 100% ethanol. 
Finally, the constructs were dried using a critical point dryer, mounted and stored in 50
ºC oven overnight. Images were taken with a JOEL 1000 SEM.  
 
3.5 Cell Proliferation 
Cell proliferation in PLCL, PLCL/chitosan, bi-layered PLCL/chitosan scaffolds 
was evaluated by Alamar Blue assays. The Alamar Blue assay is designed to 
quantitatively measure the proliferation of various human and animal cells. Briefly, 10% 
Alamar Blue (Invitrogen) solution diluted in fresh culture medium was added to the 
samples. The 10% diluted Alamar Blue culture medium was served as the blank control. 
The samples were incubated at 37°C in 5% CO2 for 4 hours. The absorbance of the 
incubated Alamar Blue solution was measured by a microplate reader (TECAN, 
infinite M200) at a wavelength of 570 nm, and600 nm as reference. The number of 
viable cells correlates with the level of dye reduction and is expressed as a percentage 
of Alamar Blue reduction, according to the manufacturer’s protocol. 
 
3.6 Histological and Immunohistochemical Assessment 
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The harvested samples were cut into two halves, and embedded with Tissue 
Freezing Medium® (Leica, Germany). The samples were cryosectioned from middle 
in 10 μm using Cryostat Microtome (Leica CM3050 S). The sections were then 
post-fixed in an ice-cold mixture of acetone and methanol (1:1) for 5 min before 
histological and immunological staining.  
 
3.6.1 Safranin O staining 
Cartilage matrix proteoglycan was stained with 0.1% Safranin O Solution (Acros 
Organics, USA) for 5 min, counterstained with Accustain® Harris hematoxylin (Sigma, 
USA) for 3 min at ambient temperature.  
 
3.6.2 Immunohistochemical Staining 
AnUltra Vision detection kit (TP-015-AF, Thermoscientific) was used. The 
sections were first blocked using hydrogen peroxide, followed by pepsin digestion for 
20 min. Type II and X collagen staining were performed using mouse monoclonal 
antibodies Clone 6B3 (diluted 1:500, Chemicon, Inc., USA) and Clone X53 (diluted 
1:25; Quartett, Berlin, Germany) at 4 º C overnight, respectively, followed by 
biotinylated goat anti-mouse (Lab Vision Corporation, USA) secondary antibody 
incubation for 2 hr. Streptavidin peroxidase was added for 45min and 
3,3'-Diaminobenzidine was used as a chromogenic agent, according to indirect 
immunoperoxidase method. After counterstained with Gill’s Hematoxylin, the slides 




3.7 Fluorescent and Immunofluorescent Analysis 
3.7.1 F-actin Staining 
Cytoskeletal organization was assessed by fluorescent F-actin staining. The whole 
constructs were fixed with 4% paraformaldehyde overnight. Then the slides were 
permeabilized in 0.1% Triton X-100 in 1ΧPBS for 10 min, and incubated with 
rhodamine phalloidin (Millipore, USA) for 15 min, washed with PBS three times, and 
added ProLong® Gold Antifade Mountant with DAPI (Invitrogen). 
 
3.7.2 Immunofluorescent staining 
After permeabilization, the slides were incubated with pSMAD2/3 (Santa Cruz 
Biotechnology, USA), pSMAD1/5/8 (Abcam, UK), SMAD2/3 (Santa Cruz 
Biotechnology, USA), SMAD1/5/8 (Santa Cruz Biotechnology, USA), integrin β1 
(Millipore, USA) primary antibodies (1:500)at 4ºC overnight. Then, 488 or 594 Alexa 
Fluor® secondary antibodies (1:2000, Invitrogen, USA) were added for 2 hr. After PBS 
wash for three times,Antifade Mountant with DAPI were added and viewed under 
Olympus FV1000 confocal fluorescence microscope.  
Quantification of fluorescence signals from microscopy generated images were 
performed using ImageJ. Different regions of the constructs were imaged, with average 
10 image fields per sample, per region. The data of integrated density was obtained by 
selecting “Integrated Density” in “Set Measurements” (Fig 14). An average of 




Fig 14. Setting window in ImageJ for measuring integrated density. 
 
3.8 Quantification ofSulfated Glycosaminoglycan (sGAG) and Collagen Type II 
(COL II) 
The constructs were digested with 10 mg/mL pepsin (Sigma, USA) in 0.05 M 
acetic acid at 4°C for 5-7 days, followed by 1 mg/mL elastase (Sigma, USA) at pH 8.0 
overnight. The digests were centrifuged at 10,000rpm for 5 mins at4°C and ready to 
analyze. 
The amount of sGAG was quantified using Blyscan sGAG assay kit (Biocolor, 
UK). Briefly, the digests were mixed with 250 μL Blyscan dye and agitating for 30 
minutes at room temperature. Following high speed centrifugation (>10,000xg) for 10 
minutes. The precipitate was collected and dissolved in 250 μL dissociation reagent. 
The samples were vortexed for 10 minutes to release the bound dye. Quantification of 
sGAG was to measure the absorbance of re-dissolved dye at a wavelength of 656nm 
using Flurostar Optima plate reader, using a standard curve generated from a standard 
sGAG solution supplied by manufacture.  
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Type II collagen was measured by using a captured enzyme-linked immunosorbent 
assay (ELISA,Chondrex, USA) following the manufacturer protocol. Generally, the 
samples and standards were incubated with detection antibody, followed by HRP 
conjugated antibody. Then stabilized chromogen was added, and stop solution was 
added. Every two steps were intervened by PBS wash. Measurement was taken on a 
TECAN Infinite M200 at an optical density of 490 nm, and the concentration of 
collagen was extrapolated from a type II collagen standard curve (supplied with the 
kit). 
The amount of both sGAG and type II collagen was normalized to its DNA 
quantity. The DNA amount was fluorometrically quantified by using Hoechst Dye 
33258 solution (Molecular Probes, Invitrogen). 
 
3.9 Real time PCR analysis 
Samples were digested in 0.25% collagenase solution, and cells were collected by 
centrifugation. Total RNA was extracted using the RNeasy® Mini Kit (Qiagen, 
Germany). RNA concentration was determined using the NanoDrop (NanoDrop 
Technologies, Wilmington, DE). Reverse transcription was performed with 100ng total 
RNA using iScriptTM cDNA synthesis kit (Bio-Rad, USA). Both RNA extraction and 
reverse transcription were done following the manufacturer’s recommendations. 
Real-time PCRs were conducted using the SYBR® green assay on ABI 7500 
Real-Time PCR System (Applied Biosystems, Life Technologies, USA). Real-time 
PCR program was set at 95ºC for 10min, followed by 40 cycles of amplifications, 
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consisting of a 15s denaturation at 95ºC and a 1 min extension step at 60ºC. The level of 
expression of the target gene, normalized to GAPDH, was then calculated using the 
2-ΔΔCt formula with reference to the undifferentiated MSC. Primer sequences used in 
this study were listed in Table 2. 
 
Table 2. The list of primers used in real time PCR analysis 
Gene Primer sequence 
GAPDH forward 5’-ATGGGGAAGGTGAAGGTCG-3’ 
reverse 5’-TAAAAGCAG CCCTGGTGACC-3’ 
AGCAN forward 5’-ACTTCCGCTGGTCAGATGGA-3’ 
reverse 5’-TCTCGTGCCAGATCATCACC-3’ 
COLII forward 5’-GGCAATAGCAGGTTCACGTACA-3’ 
reverse 5’-CGATAACAGTCTTGCCCCACTT-3’ 
COL X forward 5’-CAAGGCACCATCTCCAGGAA-3’ 
reverse 5’-AAAGGGTATTTGTGGCAGCATATT-3’ 
MMP13 forward 5’-TCCTCTTCTTGAGCTGGACTCATT-3’ 
reverse 5’-CGCTCTGCAAACTGGAGGTC-3’ 
ALP forward 5’-GGGGGTGGCCGGAAATACAT-3’ 
reverse 5’-GGGGGCCAGACCAAAGATAG-3’ 
RUNX2 forward 5’-AACCCACGAATGCACTATCCA-3’ 
reverse 5’-CGGACATACCGAGGGACATG-3’ 
COL I forward 5’-CAGCCGCTTCACCTACAGC-3’ 
reverse 5’-TTTTGTATTCAATCACTGTCTTGCC-3’ 
 
3.10 Western Blot assay 
The constructs were digested in 0.25% collagenase for 1 hr and then dissolved into 
a CelLytic M lysis buffer (Sigma, USA) supplemented with inhibitors of proteases and 
phosphatases (Roche, Switzerland), and stored at -80ºC. Protein concentration was 
determined by BCA Protein Assay kit (Pierce, USA). Equal amounts of proteins were 
electrophoreted on a NuPAGE® Novex® 10% Bis-Tris gel (Life Technologies, USA) 
at 100V before transferred onto a nitrocellulose membrane. The membranes were 
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incubated overnight with the following antibodies: pSMAD1/5/8, pSMAD2/3, 
SMAD1/5/8, SMAD2/3, integrin β1, pFAK (Millipore, USA), pERK (Cell signaling, 
USA), β-actin (Sigma, USA). All primary antibodies were applied at 1:1000 dilution. 
Blots were further incubated with the appropriate horseradish peroxidase 
(HRP)-conjugated secondary antibodies (diluted 1:5000, Thermo, USA) at ambient 
temperature for 2hrs. The immune complexes were detected with Immun-Star™ 
WesternC™ chemiluminescence kit (Bio-Rad, USA) and visualized via the ChemiDoc 
XRS Gel documentation system (Bio-Rad, USA). 
 
3.11 Mechanical strength analysis 
Compression test was carried out using Instron tester 5567 at 0.01 mm/s until the 
20% strain was reached. The thickness of the samples was measured and converted to 
the strain of the sample (e = 1 - L/L0, where L0 and L represent the thickness before and 
after compression, respectively). Young’s modulus was determined using the formula 
E = r/e, where r and e represent the respective stress and strain of the sample on the 
stress–strain plot. 
 
3.12 Statistical analysis 
Statistical significance was calculated by using factorial analysis of variance 
(ANOVA) followed by LSD-t test. Data were presented as the mean±SD, with the level 
of significance set at p < 0.05. All quantitative results were averaged from two to three 
independent experiments.  
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CHAPTER 4  




The unique viscoelastic biomechanics of articular cartilage encourage the design of 
scaffolds with elasticity and proper rigidity. The elastomeric porous PLCL scaffold that 
fulfills the above requirements was chosen for further modification.  PLCL was 
surface coated with chitosan, to provide a biomimetic surface. The objective of this 
chapter was to characterize the chitosan modified PLCL, evaluating its porosity, 
wettability and mechanical properties, and to determine its ability to support cell 
attachment, proliferation and chondrogenic differentiation, in comparison to the 
unmodified PLCL scaffold. 
 
4.2 Results 
4.2.1 Characterization of Scaffolds 
SEM images showed similar micro-structures between PLCL and PLCL/chitosan 
scaffolds (Fig 15). To further identify the composition of the (co-)polymers, a 
combination of FTIR and TGA analysis was employed. The distinct FTIR and TGA 
curves of PLCL/chitosan scaffold differed from those of either PLCL or chitosan (Fig 
16), indicating that chitosan was coated on the PLCL scaffolds using our method of 





Fig 15. SEM microphotographs of PLCL (A) and PLCL/chitosan (B) scaffold. 
 
 
Fig 16. FTIR (left) and TGA (right) spectrum of PLCL material, chitosan material and the PLCL/chitosan 
scaffold. 
 
There was no significant difference in porosity between the two types of scaffolds 
(Table 3), and the pore size of both scaffolds were 250-300μm.  Evaluation of 
wettability through contact angle measurement of water droplets showed significant 
decrease in PLCL/chitosan scaffolds (Table 3), implying that chitosan coating on 
PLCL scaffolds increased the surface hydrophilicity. Young’s modulus of 
PLCL/chitosan scaffold was significantly higher, but has similar recovery ratio as the 
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PLCL scaffold (Table 3), suggesting better mechanical strength and comparable 
elasticity. 
 
Table 3. Porosity, Wettability, and Mechanical Properties of the Scaffold 
 PLCL PLCL/chitosan 
Porosity (%) 85.5±7.9 84.5±8.2 
Contact Angle () 9.67±3.41 62.50±4.79* 
Young’s Modulus (kPa) 84.1±12.5 128±16.9* 
Recovery Ratio 0.898±0.049 0.958±0.040 
*p < 0.05 when compared with value of PLCL, n=3. 
 
4.2.2 MSC Attachment, Morphology and Proliferation in the Scaffolds 
The comparison of MSC attachment, morphology and proliferation in PLCL and 
PLCL/chitosan scaffolds was assessed in the early stage of differentiation. Sixteen 
hours after seeding, SEM images shows that the cell morphology in PLCL/chitosan 
scaffold was more elongated and spreading, while that in PLCL scaffold remained 
round and aggregate in clusters unevenly as areas of the PLCL surface were not 
occupied by MSCs(Fig 17).  
 
 
Fig 17. SEM microphotographs of MSC attached on PLCL (A) PLCL/chitosan (B) scaffold 16h after 
seeding. Arrowhead indicates the region without cell attachment. 
 
The actin organization of the MSCs was investigated by rhodamine phalloidin 
staining after 16, 48 and 72hr. Peripheral actin filaments were formed and cells 
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aggregated in PLCL/chitosan constructs while actins in PLCL constructs were still 
polymerized as stress fibers (Fig 18).Comparatively, MSC on the PLCL scaffold were 
mostly unspread and did not stain strongly with phalloidin, thus indicating a lack of 
actin polymerization at 16 h. MSCs on the PLCL scaffold only adopted a spread-up 
morphology and formed either regional punctuated F-actin fiber (Fig 18B) or stress 
fiber (Fig 18C) by 72 h. after seeding.  At 72 h, there was congregation of 
aggregated cells protruding fromthe layer of stressed F-actin cells (Fig 18 E) in the 
PLCL/chitosan scaffold (Fig 18F, region indicated by dotted line). These aggregated 
cells had lost their F-actin stress fiber, unlike the underlying cells, and had their actin 
cytoskeleton reorganized into a cortical pattern. 
 
 
Fig 18. F-actin organization of MSCs in PLCL (A–C) and PLCL/chitosan (D–F) scaffolds at 16 hr (A, D),) 
and 72 hr (B, E C, F). Dotted lines indicates region of aggregated cells adopting polygonal cell 
morphology with cortical F-actin distribution. 
 
Cell proliferation in the first week of chondrogenesis was analysed by Alamar 
Blue assay. Cells in both PLCL scaffolds and PLCL/chitosan scaffolds underwent 
increasing proliferation with time, with no significant difference (Fig 19), indicating 
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similar proliferation rate in both types of constructs. 
 
 
Fig 19. Alamar blue assay for proliferation of MSCs cultured on PLCL (white bar) and PLCL/chitosan 
(grey bar) scaffolds at 1, 3, 5 and 7 days. 
 
4.2.3 Chondrogenic Differentiation of MSC and Cartilage ECM Formation in the 
Scaffold  
Chondrogenic differentiation of MSC and cartilage ECM formation in PLCL and 
PLCL/chitosan scaffolds was evaluated through analysis of mRNA expression of 
chondrogenic markers, quantification and histological staining of ECM components. 
During chondrogenesis from week 1 to week 3, the expression of (sex 
determining region Y)-box 9 (SOX9) mRNA of the cells in both scaffolds reached a 
peak in week 2 (Fig 20). Expression of SOX9 in PLCL/chitosan scaffolds increased 
significantly from week 1 to week 2(p=0.008), compared with non-significant 
increase in the PLCL constructs. SOX9 is the transcriptional factor that directly 
activates Col2a1 and AGCAN (Sekiya et al., 2000). Time-dependent increase in 
mRNA expression of chondrogenic markers AGCAN and COL IIin both PLCL and 
PLCL/chitosan was detected. When comparing levels of expression between the two 
types of scaffolds at all time points, expression levels of AGCAN (p = 0.011 at week 
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1and p = 0.036 at week 3) and COL II (p= 0.037 at week 3) in PLCL/chitosan samples 
were significantly higher than PLCL samples. In addition, significant time-dependent 
increase expression of COL II (from week 1 to 2 and from week 2 to 3, both at p = 
0.020) was detected in PLCL/chitosan samples. Although the increasing expression of 
AGCAN mRNA in both types of constructs was insignificant, AGCAN in the 
PLCL/chitosan constructs was significantly higher than that in PLCL constructs in 
week 1 and week 3 (Fig 20). 
 
 
Fig 20. Real time PCR analysis of chondrogenic marker SOX9, AGCAN and COLII in MSC seeded PLCL 
(white bar) and PLCL/chitosan (grey bar) constructs. Expression was normalized to GAPDH and 
presented as fold changes relative to level in undifferentiated MSC.* denotes statistically significant 
difference between week X and week 1.  # denotes statistically significant between PLCL and 
PLCL/chitosan constructs in week X. 
 
Quantification of ECM components, COL II and AGCAN, by ELISA and DMB 
assays of sGAG respectively, was normalized by total DNA content in the constructs. 
Both COL II and AGCAN were expressed significantly higher in PLCL/chitosan 
constructs in the middle (week 2) and end (week 4) of the culture, compared to that in 
PLCL constructs (Fig 21). Notably, the time-dependent increase in sGAG was 
obvious and significant with the PLCL/chitosan construct (p = 0.006) but not 
significant in the PLCL construct (p = 0.35).  Earlier and higher quantity of collagen 
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Fig 21. Quantification of AGCAN and COL II of MSC in PLCL (white bar) and PLCL/chitosan (gray bar) 
constructs after 2 and 4 weeks differentiation, normalized to total DNA content. Data shown are means±
SD (n = 5). *p < 0.05 significant increase in PLCL/chitosan construct compared with PLCL construct. 
 
Considerable difference in tissue formation was observed in histological staining. 
The deposition of AGCAN and COL II in PLCL/chitosan sections was in greater 
abundance and breadth, while the tissue formation in the sections of PLCL constructs 
showed recognizable large proportion of emptiness (Fig. 22), in which much lower 
cell seeding was seen. 
 
   
Fig 22. Histological and immunohistological staining with alcian blue (A, D), safranin O (B, E) and COL II 
(C, F) for MSC seeded on PLCL (A, B, C) and PLCL/chitosan (D, E, F) scaffolds at week 4. Asterisks 
denote the top and bottom surfaces of the scaffolds. 
*               *               * 
 
   *        *      * 
*          *           * 
 




4.2.4 Mechanical Strength of Harvested PLCL and PLCL/chitosan Constructs 
The entire harvested constructs after 4 weeks of differentiation culture were 
subject to mechanical test. With tissue formation, the Young’s modulus of the PLCL 
construct (386.3±97.3 kPa) was more than 4-fold of increase over the empty PLCL 
scaffold (84.1±12.5 kPa). The Young’s modulus of the PLCL/chitosan construct 
(735.3±210 kPa) was five times as stiff as empty PLCL/chitosan scaffold (128±16.9 
kPa). The compressive modulus of the harvested PLCL/chitosan constructs was 
nearly doubled that of PLCL tissue construct (Fig 23).  
 
 
Fig 23. Young’s modulus of PLCL (white bar), PLCL/chitosan (gray bar) constructs. Data shown are 




Chitosan coating to porous PLCL scaffolds enhanced the surface hydrophilicity, 
resulting in better distribution of the cells. Meanwhile, chitosan has been well 
characterized to possess strongly positive zeta potential, i.e. the positive surface 
charge contributed to improve the attachment to negatively charged cell membrane 
(Prasitsilp et al., 2000). Moreover, the elastic nature and porosity of the PLCL were 
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not compromised in PLCL/chitosan scaffolds. As shown in SEM and actin fluorescent 
staining, the seeded MSCs were evenly distributed throughout PLCL/chitosan 
scaffold. It was demonstrated by other publications that material surface 
modifications were able to control stem cell adhesion, migration, and differentiation 
(Ayala et al., 2011). It was worth emphasizing that earlier transition of actin from 
polymerized stress fibers to cortical organization was detected in the PLCL/chitosan 
constructs. The reorganization indicated the aggregated cell morphology change into 
sphere. The process suggested possible cell condensation, an event associated with the 
activation of stem cell chondrogenic differentiation (Kim, Kim, Kang, & Jin, 2009), 
happened in PLCL/chitosan constructs prior to PLCL constructs. Overall, our data of 
scaffold characterization and early cell behavioral study demonstrated that surface 
modification of chitosan on PLCL scaffold greatly enhanced MSC distribution and 
might accelerate differentiation. 
The increase of expression in the chondrogenic markers and the formation of 
cartilaginous ECM proteins evidenced that MSC chondrogenesis took place in both 
PLCL and PLCL/chitosan scaffolds. Despite non-significant difference in cellular 
proliferation at earlier differentiation time points, the cartilaginous ECM formation in 
PLCL/chitosan construct were more robust than that in PLCL construct, resulting in a 
doubling of the mechanical strength of the tissue construct at the end of 4 weeks 
culture. Apart from the enhanced MSC chondrogenesis in the PLCL/chitosan scaffold, 
the overall increase in the mechanical strength was probably attributed to the even 
cellular distribution within the PLCL/chitosan scaffold. In contrast, the confined high 
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congregation of cells within a small region in the PLCL scaffold might have caused a 
deficit in nutrient supply locally, thus impeding MSC chondrogenesis. The low 
occupancy of cells in the rest of the PLCL scaffold due to poor cell distribution in the 
hydrophobic material prevented these loosely distributed cells from undergoing 
proper cellular condensation and chondrogenic differentiation, thus resulting in an 
overall lower total ECM formation within the PLCL construct and lower mechanical 
strength of the tissue construct. In addition, studies have reported that positive charge 
of chitosan modification on material surface increased PGs adsorption(Di Martino, 
Sittinger, & Risbud, 2005), which might contribute to the enhanced retention of the 
newly synthesized PGs and increased the compressive modulus of PLCL/chitosan 
constructs.  
Our in vitro generated cartilage on PLCL/chitosan scaffold at a Young’s modulus 
of 735 kPa was still functionally inferior to normal cartilage (~10MPa). Further 
enhancement of ECM production from the seeded would be essential to improve the 
mechanical properties of the neo-cartilage. As cartilage is a weight-bearing tissue in 
which cells within the tissue are under constant mechanical loading, to improve the 
regenerative outcome, proper mechanical stimulation mimicking physical 
rehabilitation in clinical cartilage repair would be essential to improve tissue 
generation outcome. Incorporation of a dynamic mechanical stimulation system to 
simulate physiological mechanical loading during stem cell differentiation will better 




In conclusion, the study in this chapter demonstrated that chitosan coating of the 
elastomeric PLCL scaffold improved chondrogenic differentiation in vitro. The 
resulting PLCL/chitosan scaffold has improved wettability and permeability for cell 
attachment and distribution. The morphology of cells in PLCL/chitosan scaffold 
suggested an early induction of differentiation. Through the evaluation of 
chondrogenic markers and ECM components, the level of chondrogenesis in 
PLCL/chitosan constructs was higher with increase production of COL II and 
AGCAN simultaneously. As a result, PLCL/chitosan constructs possessed better 
mechanical properties than PLCL constructs. The elastomeric PLCL/chitosan scaffold 
was subsequently applied to study the effect of dynamic compressional loading and 






The effect of deferral dynamic compressionon mesenchymal stem cell 
chondrogenic hypertrophy development 
 
5.1 Background 
In this study, the effect of deferral dynamic compression (DC) on chodrogenesis 
of MSCs cultured inthe elastomeric PLCL/chitosan was investigated. A deferral 
dynamic compression regime was chosen as loading applied before sufficient 
pericellular matrix was produced has been reported to have an inhibitory effect on 
MSC chondrogenesis (Haugh et al., 2011; Huang, Farrell, Kim, & Mauck, 2010). 
Delayed dynamic loading, provided after a chondrogenic preculture period, on the 
other hand, was shown to be beneficial for MSC chondrogenesis (Li et al., 2012).The 
effect of deferral compression on MSCs’ morphology, cytoskeleton arrangement, 
chondrogenic differentiation and hypertrophic phenotype was investigated and 
compared with those under free swelling (FS) condition. The involvement of the two 
branches of R-SMAD signaling pathways and mechano-transduction cross-talk with 




5.2.1Chondrogenic Differentiation of MSCs and ECM Formation  
MSC seeded PLCL/chitosan constructs were allowed for 3 weeks of free swelling 
66 
 
chondrogenic differentiation before subjecting to 3 weeks of deferral dynamic 
compression (DC) under the same chondrogenic condition (Fig. 13 A & B).  Safranin 
O staining and immunohistochemical analysis showed abundant deposition of 
AGCAN and COL II in the deferral dynamic compression samples, compared with 
those in free swelling culture (Fig. 24A). Real time PCR analysis showed significant 
increase of AGCAN and COL II RNA expression levels in the dynamic compression 
samples compared to the free swelling samples at week 6 (Fig. 24B). Quantification 
of the sGAG and COL II protein contents showed doubling of the two matrix proteins 
in the dynamic compression samples (Fig. 24C). Although mRNA level of AGCAN in 
free swelling constructs increased from week 3 to week 6, the sGAG level did not 
increase when normalized to DNA. With regard to COL II expression, no significant 
increase in both mRNA and protein levels were detected in the free swelling samples 





Fig 24. Evaluation of ECM components and mechanical strength of the constructs. (A) Histological 
analysis by Safranin O staining for proteoglycan, and collagen II immunohistochemical staining of free 
swelling (FS) and dynamic compression (DC) constructs. (B) Real-time PCR quantification of AGCAN 
and COL II in the cells under free swelling (white bar) and dynamic compression (grey bar). Expression 
was normalized to GAPDH and presented as fold changes relative to level in undifferentiated MSC. Data 
shown are means ± SD, n=6. (C) Quantification of sGAG and collagen II in the constructs under free 
swelling (white bar) and dynamic compression (grey bar). Expression was normalized to DNA content in 
the respective construct. Data shown are means ± SD. n=5. (D) Young’s modulus of MSCs-seeded 
PLCL/chitosan constructs at the week 3 and 6 under free swelling (white bar) and dynamic compression 
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(grey bar). Data shown are means ± SD, n=5. * denotes statistically significant difference between week 
6 dynamic compression and free swelling constructs.  # denotes statistically significant increase in the 
constructs under free swelling from week 3 to week 6. Δ denotes statistically significant increase in the 
constructs under dynamic compression from week 3 to week 6. 
 
5.2.2 Mechanical Strength of Constructs after Deferral Dynamic Compression 
The cell constructs harvested at week 6 were subject to mechanical test. The 
mechanical strength increased significantly by about 2-folds in the free swelling 
constructs from week 3 to week 6. Significant higher increased in the Young’s 
Modulus was detected in the deferral dynamic compression constructs compared to 
the free swelling constructs at week 6. The 3-week deferral dynamic compression 
enhanced the strength of the constructs (569.93±108.47 kPa) for more than 2 folds, 
compared with the week 6 free swelling constructs (Fig. 24D).  
 
5.2.3Suppression of Hypertrophy under Deferral Dynamic Compression 
The effect of deferral dynamic compression on hypertrophic development of the 
differentiated MSC was analyzed. Immunohistochemical staining of the hypertrophic 
marker, COL X, was not detectable in the deferral dynamic compression constructs, 
compared with positive staining in the free swelling constructs (Fig. 25A). mRNA 
analysis showed a 2-fold up-regulation of COL X under free swelling condition from 
week 3 to week 6, whereas, no increase was detected under dynamic compression 
over the same period (Fig. 25B).  
 Expression of other hypertrophic markers, MMP13, ALP and RUNX2, were also 
investigated to confirm the effect of dynamic compression on hypertrophy 
development (Fig. 25B). The mRNA levels of MMP13 and ALP under free swelling 
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increased steadily from week 3 to week 6. Comparatively, under dynamic 
compressive condition, increase in MMP13 expression was not detected and 
expression of ALP was significantly suppressed at week 6 compared to week 3. For 
RUNX2, the expression level of both groups was decreased at week 6; however, level 
of expression was significantly down-regulated further under dynamic compression. 
 
Fig 25. Analysis of hypertrophic development. (A) Immunohistological staining of COL X at week 6 under 
free swelling (FS) and deferral dynamic compression (DC). (B) Real-time PCR quantification of 
hypertrophic markers, COL X, MMP13, ALP and RUNX2, at week 3 and week 6 under free swelling 
(white bar) and dynamic compression (grey bar). Expression was normalized to GAPDH and presented 
as fold changes relative to level in undifferentiated MSC. Data shown are means ± SD (n=6). * denotes 
statistically significant difference between week 6 dynamic compression and free swelling constructs.  # 
denotes statistically significant difference in the constructs under free swelling from week 3 to week 6. Δ 
denotes statistically significant decrease in the constructs under dynamic compression from week 3 to 
week 6. 
 
5.2.4Cell Morphology and Cytoskeleton Organization  
The morphology and cytoskeleton organisation of the differentiated MSCs in the 
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constructs was analysed after phalloidin staining of the F-actin, in comparison to 
primary chondrocytes and MSCs seeded in the same scaffold after one day of 
chondrogenic condition. Chondrocytes adopted a round morphology with peripheral 
actin filaments (Fig. 26A), while MSC displayed polarized stress F-actin fibers (Fig. 
26B). Cells at the end of 3-week dynamic compression exhibited similar F-actin 
distribution pattern as the chondrocytes, with peripheral actin filaments (Fig. 26C). In 
comparison, cells subjected to free swelling condition acquired a similar elongated 
morphology and have polarized F-actin distribution as the undifferentiated MSCs in 
day 1 (Fig. 26D). Quantification of the integrated density of F-actin confirms the 
weaker signals of F-actins in the cells under dynamic compression, compared with 
those under free swelling (Fig. 26E).  
 
 
Fig 26. F-actin distribution and quantification of chondrocytes (A) and MSCs (B, C, D) in PLCL/chitosan 
scaffolds under free swelling (FS) and dynamic compression (DC). Phalloidin staining (red) was 
performed at day 1 (A, B) after cell seeding, or after 6 week of differentiation (C, D) and Nucleus was 
71 
 
stained with DAPI (blue). Scale bar = 10μm. (E) Integrated density evaluation of F-actin by ImageJ. * 
denotes significantly weaker signal in the deferral dynamic compression (dark red) cells than in free 
swelling (light red) cells at week 6. Data shown are means ± SD, n=7. 
 
5.2.5Regulation of TGF-β/SMAD Signaling Pathways 
R-SMADs are intracellular mediators activated by phosphorylation upon TGF-β 
/SMAD signaling. The expression levels of pSMAD2/3 and pSMAD1/5/8 were 
analysed by immunofluorescent staining (Fig. 27A & B). Both pSMAD2/3 and 
pSMAD1/5/8 were detectable after 3 week of differentiation under the free swelling 
condition. Expression of pSMAD2/3 decreased slightly with further 3 weeks of free 
swelling condition but maintained at a significantly higher level under deferral 
dynamic compression condition.  In contrast, pSMAD1/5/8 increased significantly 
by week 6 under free swelling, but reduced to levels lower than week 3 free swelling 
after deferral dynamic compression. Western blot results further confirmed the 
increment of pSMAD2/3 and insignificant change of pSMAD1/5/8 under deferral 
dynamic compression, in contrast to the maintenance of pSMAD2/3 and the 





Fig 27. pSMADs distribution and quantification in PLCL/chitosan scaffolds. (A) pSMAD2/3 (green) and 
pSMAD1/5/8 (red) staining of cells in PLCL/chitosan scaffolds under free swelling (FS) at week 3 and 6, 
and under deferral dynamic compression (DC) at week 6. Nucleus was counterstained with DAPI (blue). 
Scale bar = 10μm. (B) Integrated density evaluation of pSMAD2/3 and pSMAD1/5/8 by ImageJ. * 
denotes significantly different signal intensity in deferral dynamic compression (dark green and red, 
respectively) than in free swelling (light green and red, respectively) at week 6. Data shown are means ± 
SD, n=8. (C) Western Blot of phosphorylated and non-phosphorylated SMAD2/3 and SMAD1/5/8 at week 
3 and week 6 under free swelling (FS) and deferral dynamic compression (DC). (D) Integrated density 
evaluation of pSMAD2/3 (green line) and pSMAD1/5/8 (red line) western blots by ImageJ.  
Phosphorylated SMADs are normalized to the respective transcripted SMADs (tSMAD). * denotes 
statistically significant difference between week 6 dynamic compression and free swelling constructs.  # 
denotes statistically significant difference in the constructs under free swelling from week 3 to week 6. Δ 
denotes statistically significant difference in the constructs under dynamic compression from week 3 to 
week 6. 
 
5.2.6Regulation of Integrin β1/FAK Signaling  
As integrins are transmembrane receptors connecting the cells with ECM, and β1 
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subunits initiate pathways affecting cell adhesion, it has been hypothesized that 
integrin β1 transduces extracellular physical force into intracellular biochemical 
signals during chondrogenesis (Millward-Sadler & Salter, 2004). 
 The expression of integrin β1 was examined by immunostaining and western 
blotting. Expression of integrin β1 was significantly increased in free swelling by 
week 6 while remained at lower level as in week 3 under dynamic compression (Fig. 
28A & B). Expression pattern of integrin β1 was further validated on western blot 
showing suppression of expression under deferral dynamic compression compared 
with the free swelling samples (Fig. 28C & D). Analysis of the downstream mediators 
of integrin β1 signaling cascade, phosphorylated focal adhesion kinase (pFAK) and 
activated extracellular signal–regulated kinase (pERK) (Giancotti, 1999), showed 
up-regulated expression in free swelling constructs and reduced expression in deferral 





Fig 28. Integrin β1 distribution and quantification. (A) Integrin 1 staining (green) of cells in constructs 
under free swelling (FS) at week 3 and 6, and under deferral dynamic compression (DC) at week 6. 
Nucleus was counterstained with DAPI (blue). Scale bar = 10μm. (B) Integrated density evaluation of 
integrin β1 by ImageJ. Free swelling is in light green bar, and deferral dynamic compression in dark 
green bar. Data shown are means ± SD (n=10). (C) Western Blot of integrin β1, pFAK, pERK and β-actin 
at week 3 and week 6 under free swelling (FS) and deferral dynamic compression (DC). (D) Integrated 
density evaluation of integrin β1 (blue line), pFAK (red line) and pERK (green line) western blots by 
ImageJ. Expression levels are normalized to the levels of β-actin. * denotes statistically significant 
difference between week 6 dynamic compression and free swelling constructs.  # denotes statistically 
significant difference in the constructs under free swelling from week 3 to week 6. 
 
5.2.7Inhibition of TGF-β/Activin/Nodal Signaling by SB431542 
SB431542 (SB) is a specific inhibitor of activin/nodal/TGF-β signaling pathway, 
inhibiting specifically activin receptor-like kinase-5 (ALK5)(Inman et al., 2002). SB 
was added in both free swelling and deferral dynamic compression samples after the 
initial 3-week free swelling differentiation (Fig. 13A & B). Expression of 
chondrogenic and hypertrophic markers was compared to the respective samples in 
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the absence of inhibitors (Fig. 29). Treatment with SB abolished the increase of 
AGCAN and COL II mRNA expression from week 3 to week 6 in both free swelling 
and dynamic compression samples. Expression of these two chondrogenic markers 
remained unchange as that of week 3 samples, prior to the addition of the inhibitor. 
Both the free swelling and dynamic compression samples with SB treatment 
expressed excessive increase of hypertrophic markers, MMP13, ALP and RUNX2, 
compared with the respective untreated control. Increased in Col X in the dynamic 




Fig 29. The expression of ECM components and hypertrophic markers in TGF-β/Activin/Nodal inhibition 
study. Real-time PCR quantification of ECM components – AGCAN and COL II, and hypertrophic 
markers – COL X, MMP13, ALP and RUNX2, in the cells under free swelling in week 3 (white bar), free 
swelling with SB431542 treatment (FS+SB) in week 6 (light stripped bar), deferral dynamic compression 
in week 6 (grey bar) and deferral dynamic compression with SB431542 treatment (DC+SB) in week 6 
(grey stripped bar). Expression was normalized to GAPDH and presented as fold changes relative to 
level in undifferentiated MSC. Data shown are means ± SD (n=6).  * denotes statistically significant 
difference in DC+SB constructs compared to FS+SB constructs at week 6.  ## denotes statistically 
significant difference between FS and FS+SB constructs at week 6. ΔΔ denotes statistically significant 
difference between DC and DC+SB constructs at week 6. 
 
5.2.8Effect of TGF-β/Activin/Nodal Signaling Inhibition on Integrin β1/FAK 
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Signaling and BMP/GDP Branch Signaling  
Under deferral dynamic compression, TGF-β/Activin/Nodal signaling was 
up-regulated while BMP/GDP branch and integrin β1/pFAK/pERK signaling were 
suppressed. To investigate the effect of TGF-β/Activin/Nodal signaling on integrin 
β1/FAK and BMP/GDP branch signaling, the expression level of phosphorylated 
SMAD1/5/8 and integrin β1, pFAK and pERK, were analyzed after SB treatment to 
both free swelling and dynamic compression. Non-treatment groups in both the free 
swelling and deferral dynamic compression constructs were set as control (Fig. 30). 
SB treatment significantly up-regulated the expression of pSMAD1/5/8 and integrin 
β1 in the both the free swelling and dynamic compression constructs as shown by 
immunohistochemical (Fig. 30A & B) and Western blot analysis (Fig. 30C & D). The 
suppression of pSMAD1/5/8 and integrin β1 by dynamic compression to that of free 
swelling was partially reversed by SB treatment. Western blot analysis indicates a 
further up-regulateion of pFAK and pERK in the free swelling samples with SB 
treatment (Fig. 30C & D). However, the effect of SB treatment on the dynamic 
compression was less obvious; with pFAK expression remained below that of free 





Fig 30. The distribution and quantification of pSMAD1/5/8 and integrin β1 with inhibition of 
TGF-β/Activin/Nodal signaling. (A) Immunofluorescent staining of pSMAD1/5/8 (red) and integrin β1 
(green) in the constructs at week 6 under free swelling (FS), free swelling with SB431542 treatment 
(FS+SB), deferral dynamic compression (DC) and deferral dynamic compression with SB431542 
treatment (DC+SB). Scale bar = 10μm. (B) Integrated density evaluation of pSMAD1/5/8 and integrin β1 
by ImageJ. The samples without SB431542 treatment are exhibited in vertical stripped bars, and those 
with SB431542 treatment are in diagonal stripped bars.  (C) Western Blot of phosphorylated and 
non-phosphorylated SMAD1/5/8, integrin β1, pFAK, pERK and β-actin. (D) Integrated density evaluation 
of SMAD1/5/8 (red line), integrin β1 (green line), pFAK (blue line) and pERK (purple line) western blots by 
ImageJ. Phosphorylated SMAD1/5/8 is normalized to transcripted SMAD1/5/8. Expression levels of 
integrin β1, pFAK and pERK are normalized to the levels of β-actin. * denotes statistically significant 
difference in the DC+SB constructs compared to FS+SB constructs.  ## denotes statistically significant 
difference between FS and FS+SB constructs. ΔΔ denotes statistically significant difference between DC 




5.2.9Inhibition of Integrin Interaction on MSC Chondrogenesis and 
TGF-β/SMAD Signaling Pathways  
As integrin β1 signaling was shown to be up-regulated in free swelling condition 
but suppressed under deferral dynamic compression, we next examine the effect of 
inhibiting integrin signaling on the free swelling samples. To inhibit integrin signaling, 
BD552828 (BD) was added to the free swelling samples after the initial 3-week 
differentiation (Fig. 13). Expression of chondrogenic and hypertrophic markers at 
week 6 was compared to free swelling sample in the absence of inhibitor (Fig. 31). 
Inhibiting integrin did not have significant effect to collagen II expression but 
up-regulate the expression of AGCAN. Although no significant change was detected 
on RUNX2 and ColX expression, MMP13 and ALP expression at week 6 was 
suppressed after BD treatment, in comparison to a significant increase in free swelling 
samples without BD treatment.   
 
 
Fig 31. The expression of ECM components and hypertrophic markers with integrin β1 inhibition in free 
swelling conditions. Real-time PCR quantification of ECM components – AGCAN and COL II, and 
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hypertrophic markers – COL X, MMP13, ALP and RUNX2,in the cells under free swelling (white bar) and 
free swelling with integrin inhibition (grey bar). Expression was normalized to GAPDH and presented as 
fold changes relative to level in undifferentiated MSC. Data shown are means ± SD (n=6).  ## denotes 
statistically significant difference between integrin β1 antibody treatment and non-treated samples at 
week 6. 
 
The effect of integrin β1 signaling inhibition to TGF-β/SMAD signaling was 
investigated for possible crosstalk between integrin β1/pFAK/pERK and 
TGF-β/SMAD pathways. Immunofluorescent staining of pSMAD2/3 and 
pSMAD1/5/8 showed that under BD treatment, cells exhibited increased 
phosphorylation of SMAD2/3 with dramatic suppression of SMAD1/5/8 
phosphorylation (Fig. 32A & B). Expression patterns of pSMAD2/3 and 






Fig 32. The distribution and quantification of pSMAD2/3 and pSMAD1/5/8 at week 6 in free swelling 
samples with or without integrin β1 inhibition. (A) Immunofluorescent staining of pSMAD1/5/8 (red) and 
pSMAD2/3 (green) in the samples at week 6 under free swelling (FS) and free swelling with integrin β1 
inhibition (FS+BD). Scale bar = 10μm. (B) Integrated density evaluation of pSMAD2/3 (green) and 
pSMAD1/5/8 (red) by ImageJ. (C) Western Blot of phosphorylated and non-phosphorylated SMAD2/3 
and SMAD1/5/8. (D) Integrated density evaluation of pSMAD2/3 (green line) and pSMAD1/5/8 (red line) 
western blots by ImageJ. Phosphorylated SMADs are normalized to the respective transcripted SMADs 
(tSMAD). ## denotes statistically significant difference between integrin β1 antibody treatment and 







Mechanical stimulation in the form of compressional loading has been reported to 
play important roles in regulating MSC chondrogenic differentiation (Responte, Lee, 
Hu, & Athanasiou, 2012; Verteramo & Seedhom, 2007).  However, there remains a 
huge gap in understanding the contributing factors of dynamic compression in 
regulating MSC chondrogenesis, especially in relationship to the hypertrophy 
development of the neo-cartilage.  In the present study, the effect and mechanism of 
deferral dynamic compression on MSC chondrogenesis in a PLCL/chitosan scaffold 
was explored. Application of 3-week deferral dynamic compression on 
PLCL/chitosan constructs promoted enhanced expression of ECM components and 
mechanical strength of the construct (Fig. 24). This is in line to numerous studies 
showing the beneficial effect of moderate and delayed dynamic compression on the 
improvement of cartilage formation when the parameters were within the range of 1-5% 
of strain and 0.1-1Hz of frequency with less than 4 hours per day of dynamic 
stimulation (O'Conor, Case, & Guilak, 2013).  Under our stimulation parameter, the 
increase in ECM formation with deferral dynamic compression was accompanied by a 
suppression of hypertrophy development (Fig 25). Contrasting results on hypertrophy 
induction under compressive stimulation has been reported, including Huang et al 
showing long-term dynamic loading inducing hypertrophy development (Huang, 
Farrell, & Mauck, 2010), but other reports on the stabilization of chondrocytes 
phenotype by dynamic compression (Bian, Zhai, Zhang, Mauck, & Burdick, 2012) 
and hydrostatic pressure (Vinardell et al., 2012). The variability of outcomes 
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indicates the sensitivity of MSC to the dynamic parameters, such as loading intensity, 
duration and frequency, as well as the properties of the scaffold and the differentiation 
stage of the MSC.  
 Progression of MSC-derived chondrogenic cells towards hypertrophy is 
inevitable in in vitro culture(Yang et al., 2012). In accordance to previous reports, the 
phenotype of the MSC-derived cartilage in free-swelling conditions was not 
maintained in long term in vitro culture (6 weeks), even with the provision of TGF-β.  
Analysis of the phosphorylation of SMAD2/3 and SMAD1/5/8 in the free swelling 
samples shows an increase of pSMAD1/5/8 expression at the later time point, while 
pSMAD2/3 levels remained unchanged (Fig. 27), indicating a shift from the 
TGF-β/Activin/Nodal signaling to the BMP/GDP signaling at the later stage that 
likely contribute to the hypertrophic development (Hellingman et al., 2011). In 
contrast, deferral dynamic compression enhanced TGF-β/SMAD2/3 activation with 
concomitant suppression of the BMP/GDP/SMAD1/5/8 signaling. The re-balancing 
of the TGF-β/SMAD signaling might be a result of increasing endogenous TGF-β 
production induced by compressive stimulation (Li et al., 2012). Nevertheless, this 
shift in the balance between the two branches of TGF-β/SMAD signaling towards 
TGF-β/Activin/Nodal signaling likely act to antagonise the terminal chondrogenic 
differentiation under the dynamic compression conditions. This was evidence with 
inhibition study targeting activin/nodal/TGF-β signaling pathway, which resulted in 
heighten hypertrophy development and activation of the BMP/GDP signaling in the 
free swelling samples, and the reversal of dynamic compression-suppressed 
83 
 
hypertrophy development, despite a lack of further increment of collagen II and 
aggrecan (Fig. 29), along with the up-regulation of BMP/GDP signaling to a level 
similar to the free swelling condition (Fig. 30). 
 Analysis of the cellular morphology shows formation of cortical actin in cells of 
the deferral dynamic compression samples that resembles those found in primary 
chondrocytes. In contrast, F-actin stress fibers were formed in cells of 6-week free 
swelling samples (Fig. 26). The formation of F-actins stress fibers in the free swelling 
samples might be related to the activation of the BMP/GDP/SMAD1/5/8 signaling 
pathway as the downstream binding protein of type II BMP receptor (BMPR-II), LIM 
kinase (LIMK), is a well-established actin-binding kinase which regulates actin 
dynamics by regulating cofilin (Foletta et al., 2003). Activation of BMP/GDP branch 
might have released LIMK from BMPR II, which in turn phosphorylated cofilin, 
stabilizing the polymerization of F-actin.  
 The adaptation of differential cellular morphology and cytoskeletal organization 
in the free-swelling and dynamic compression samples was further correlated to the 
integrin β1 expression. Integrin β1 serves as the subunit of integrin receptors for 
collagen, facilitating cellular cytoskeletal interaction with ECM components, and has 
been shown to affect cytoskeleton organization, proliferation, differentiation, and gene 
expression in many cell types (Takada, Ye, & Simon, 2007).  Upon the binding to 
ECM proteins, integrins cluster together and small Rho GTPases are activated 
regulating polymerisation and assembly of actin filaments which lead to the formation 
of focal adhesions and stress fibers(Amano et al., 1997). Our result shows that the 
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integrin β1 expression level was indeed up-regulated in the free swelling samples 
where F-actin stress fibers were observed, and was at a much reduced levels in the 
dynamic compression cells with cortical actin filament formation (Fig. 28).  
 Integrin engagement with ECM is pivotal in initiating an early and robust 
chondrogenic differentiation (Raghothaman et al., 2014). Integrins may contribute as 
important transducers of mechanical stimuli across cell membrane by linking ECM to 
the cytoskeletal and intracellular signaling pathway via the 
integrin-FAK-MAPK/ERK axis (Saleem et al., 2009). Integrin mediated FAK 
activation and ERK signaling is required for precartilage condensation in the early 
stage of chondrogenesis (Bang et al., 2000; Jin, Choi, Kyun Park, Bang, & Kang, 
2007). On the other hand, increase phosphorylation of ERK has also been implicated 
with hypertrophic chondrocytes (Prasadam et al., 2010). In this report, we show that 
higher level of integrin β1 expression, with FAK and ERK activation, in free swelling 
samples at the later stage of MSC chondrogenesis, coincide with hypertrophy 
development (Fig. 6). This contrast with suppressed expression of integrin β1 and 
FAK/ERK activation in the deferral dynamic compression samples, in which 
hypertrophy development was curtailed. Indeed, integrin-ECM interaction has also 
been associated with chondrocyte hypertrophy (Hirsch, Lunsford, Trinkaus-Randall, 
& Svoboda, 1997; Johnson, Rose, & Terkeltaub, 2008). To further support the role of 
integrin signaling in hypertrophy development in the free swelling condition, integrin 
β1 antibodies were used to disrupt integrin-ECM interaction. Hypertrophy was 
partially reduced as seen in the down-regulation of MMP13 and ALP (Fig. 31). We 
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also detected a reinforced TGF-β/Activin/Nodal signaling and an abated BMP/GDP 
signaling with the partial inhibition of hypertrophic development (Fig. 32), indicating 
regulation of the TGFβ/SMAD signaling pathways by integrin signaling. Cross-talk 
between integrin signaling and SMAD1/5/8 activation has been reported in bone 
generation (Liu et al., 2013) and shear-regulated tumor growth arrest (Chang et al., 
2008). It is thus possible that prolong engagement of integrin-ECM interaction during 
MSC chondrogenesis could have led to MSC-derived chondrocyte development to 
hypertrophy via integrin/FAK/ERK activation of the BMP/SMAD1/5/8 signaling 
pathway, as in the case in the free-swelling samples. Conversely, cross-talk between 
the integrin signaling and TGF-β/Activin/Nodal might have also play a role in 
regulating the integrin signaling. When inhibiting the TGF-β/Activin/Nodal branch, 
apart from BMP/GDP signaling up-regulation, we detected enhancement of integrin 
β1/FAK/ERK signaling activation in both the free swelling and dynamic compression 
samples (Fig. 30). However, deferral dynamic compression appeared to have 
countered the TGF-β/Activin/Nodal inhibition effect by maintaining BMP/GDP 
signaling, and pFAK and pERK activation at a similar level to that of the 
non-inhibited free swelling group, with incomplete activation of hypertrophic 
development. This suggests of the involvement of SMAD-independent pathway in 
dynamic compression-regulated chondrogenesis. 
 It is known that the integrin family has bidirectional signaling ability, with 
outside-in and the inside-out signaling (Hynes, 2002). In the early stage of 
chondrogenesis, MSC adhesion to the ECM trigger the outside-in signaling of integrin 
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β1, governed by cytoskeletal reorganisation, regulates intracellular signaling, plays an 
indispensable role in cellular condensation (Raghothaman et al., 2014; Bang et al., 
2000; Jin, Choi, Kyun Park, Bang, & Kang, 2007). However, continuous activation of 
integrin signaling under free swelling condition might have resulted in the biasing 
towards the BMP/SMAD 1/5/8 signaling, contributing to hypertrophy development. 
On the other hand, dynamic compression might have offset the connection between 
integrin and ECM, and/or through inside-out intracellular signaling(s), including the 
TGF-β/Activin/Nodal signaling, regulated the integrin function (Fig. 33). Taken 
together, our study indicates that deferral dynamic compression, applied after the 
initiation of MSC chondrogenic differentiation, lead to reduction in integrin 
expression, suppression of FAK and ERK activation, together with SMAD2/3 
signaling up-regulation, possibly acted in concert to maintain cartilage phenotype. 
Further studies are required to elucidate the specific mechanisms involved in the 
subtle and delicate balances and cross-talk between the TGF-β/SMAD and the 




Fig 33. Schematic illustration of the possible cross-talks between TGF-β/SMAD and integrin signaling in 
the regulation of MSC chondrogenesis and hypertrophy. Mechenotransduction from deferral dynamic 
compression (black arrows) might result in (i) suppression of integrin β1/FAK/ERK pathway and, (ii) 
enhancement of TGF-β/Activin/Nodal branch, both acted in concert to (iii) down-regulate BMP/GDP 
branch, resulted in suppression of hypertrophy.The regulatory directions of cross-talk during free swelling 
are indicated in grey arrows. 
 
 In summary, we demonstrated that deferral dynamic compression suppressed 
chondrocyte hypertrophy by regulating the TGF-β/SMAD and integrin β1/FAK/ERK 
signalings.  Significantly, our results suggest cross-talk between these two pathways 
in regulating the downstream signaling, including BMP/SMAD1/5/8 signaling, under 
the dynamic compression-controlled hypertrophy development of the MSC-derived 
neo-cartilage.  This study highlights the complexity of the mechanotransduction 






The effect of dual-axis mechanical loading on MSC chondrogenic differentiation 
in a bilayered PLCL/chitosan scaffold 
 
6.1 Background 
As articular loading is mainly composed of compression and shearing, the 
objective of this chapter is to investigate the effect of dual axis stimulation consist of 
both dynamic compression and shearing, to MSC chondrogenesis. The unilayered 
PLCL/chitosan scaffold is upgraded to a bilayered scaffold with pore-size variation 
consisting of a smaller pore layer to withstand both dynamic compression and 
shearing. The bilayered scaffold was characterized for its porosity and the mechanical 
modulus of each layer, as well as the overall recovery ratio. MSC attachment and 
proliferation in each layer of the bilayered PLCL/chitosan scaffold was evaluated.  
MSC chondrogenic differentiation and zonal markers expression after dual-axis 
loading was studied, in comparison to scaffold subjected to free swelling conditions. 
 
6.2 Results 
6.2.1 Characterization of Bilayered Scaffolds 
The SEM images showed that the scaffold was horizontally laminated as two 
layers with two distinct pore sizes (Fig 34). The integration of two layers was 
harmonious with no observable gaps. Large pores (LP, 250–300μm) were 
approximately twice the size of small pores (SP, 100–150μm) (Table 4). The thickness 
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of the layer with small pore was half that of the large pore. The overall porosity of 
bilayered scaffold was decreased slightly compared with unilayered PLCL/chitosan 
scaffold (pore size: 250–300μm) (Table 5). The mechanical properties of each layer 
were evaluated separately for their Young’s modulus. There was significant difference 
in Young’s modulus between the two layers. The layer with small pore had up to 
four-fold increase in stiffness, compared with the layer with large pore (Table 4). On 
the contrary, the recovery ratio of both unilayered scaffold and bilayered scaffold was 
maintained at similar level, thus indicating a consistent elasticity (Table 5). 
 
 
Fig 34. SEM microphotographs of bilayered PLCL/chitosan scaffold (A) and magnified images of layer 
with large pore (B) and with small pore (C). The dotted line in A indicates the interface of two layers. 
 
Table 4. Young’s Modulus and pore size of each layer in the bilayered PLCL/chitosan scaffold  
 Young’s Modulus (MPa)  Pore Size (μm)  
Large Pore layer  0.13±0.017 250–300 
Small Pore layer  0.58±0.006* 100–150 
*p < 0.05 when compared with value of large pore layer. 
 
Table 5. Porosity and recovery ratio of unilayered and bilayered PLCL/chitosan scaffold 
 Unilayered PLCL/chitosan 
scaffold (pore size: 250–300μm) 
Bilayered 
PLCL/chitosan scaffold 
Porosity(%) 84.5±8.2 80.3±11.3 
Recovery ratio 0.958±0.04 0.961±0.7 
 
6.2.2 Cell Proliferation, Distribution, and Morphology in the Scaffold 
MSC proliferation was assessed every two days in the first week of chondrogenic 
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differentiation. Both unilayered and bilayered PLCL/chitosan scaffolds exhibited 
significant increases in proliferation during differentiation (Fig 35A). The 
proliferation rate between the unilayered and bilayered constructs was similar at all 
time points. The distribution of the cells seeded in the scaffolds was evaluated through 
the observation of DAPI fluorescence (Fig 35B & C). The cells in both two layers 
distributed evenly in similar density as early as in the first day of differentiation. The 
morphology of the cells in both layers was evaluated by phalloidin staining of the 
F-actin. Cells in both scaffolds were elongated with F-actins polymerized forming 
stress fibers.  
 
 
Fig 35. (A) Cell proliferationof unilayered PLCL/chitosan constructs (white bar) and bilayered 
PLCL/chitosan constructs (gray bar) scaffolds at 1, 3, 5,and 7 days. (B-C) F-actin staining (red) in 
bilayered PLCL/chitosan constructs at day 1, nucleus was stained in blue. (B) The layer with small pore, 
(C) layer with large pore. 
 




MSC seeded bilayered PLCL/chitosan constructs were allowed for 3 weeks of 
free swelling (FS) chondrogenic differentiation before subjecting to 3 weeks of 
deferral dynamic dual-axis (DA) mechanical stimulation under the same 
chondrogenic condition. At the end of the differentiation at week 6, the two layers 
were physically separated. Comparative analysis of cartilaginous markers expression 
with real-time PCR was conducted separately on each layer (Fig. 36). Real-time 
expression of AGCAN and COL II was significantly higher in LP compared to SP 
under free swelling conditions at week 3. Although continuous increase in expression 
of both makers at free swelling conditions can be seen at week 6, however, the higher 
expression in LP was only observed with AGCAN. Under DA condition, expression of 
AGCAN was significantly suppressed in the SP layer when compare to the free 
welling sample at week 6, but not in the LP layer. DA stimulation increased COLII 
expression in the SP layer but exert no significant effect in the LP layer between DA 
and FS group. Expression pattern of COL II RNA was further confirmed with COL II 
protein expression, and level of expression was semi-quantified by integrated density 
analysis of the immunofluorescent images (Fig. 37). The signals in the DA samples 
were stronger than those in FS samples for both SP and LP layers. The COL II 
staining in SP layer in DA samples displayed a more intense and compact 
organization, than those in the LP layer, further confirmed the significant higher 





Fig 36. Real-time PCR quantification of chondrogenic markers - AGCAN and COL II. # denotes 
statistically significant difference between layer with large pore (LP) and that with small pore (SP) under 
free swelling in week 3. Δ denotes statistically significant decrease in the SP layer under dynamic 
dual-axis loadingin week 6, compared with same layer under free swelling. SP+free swelling: white solid 
bars, LP+free swelling: grey solid bars, SP+dual-axis loading: wavy stripped bars with white background, 





Fig 37. Immunofluorescent staining of COL II (green) (A-D) in the cells under dual-axis (DA) loading and 
free swelling (FS), measured separately in layers with large pore (LP) and small pore (SP). (E) Integrated 
density was evaluated by ImageJ. Δ denotes statistically significant differencebetween LP (dark green) 
and SP (light green) under DA loading. 
 
6.2.4 Expression of Superficial Zone Cartilage Markers 
As a combination of compression and shearing was generated by dual-axis 
stimulation, the mRNA expression of superficial zone markers – COLI and PRG4, 
was analyzed (Fig. 38). Under free swelling condition at week 3, no different in 
expression of COL I was detected between SP and LP layers, however, PRG4 
expression was significantly higher in the LP layer.  Expression of both markers 
increased further at week 6, with no significant different between the SP and LP layers. 
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Under DA condition, expression of COL I further increased significantly in both SP 
and LP layers. DA stimulation up-regulated PRG4 expression only in the SP layer. 
 
 
Fig 38.Real-time PCR quantification of zonal markers - COL I and PRG4, in the constructs of different 
layers from week 3 to week 6.SP: layer with small pore, LP: layer with large pore, FS: free swelling, DA: 
dual-axis loading. # denotes statistically significant difference in the cells between LP+FS and SP+FS at 
week 3. Δ denotes statistically significant difference between DA and FS in SP layer at week 6. ## 
denotes statistically significant difference between DA and FS in LP layer at week 6 
 
6.3 Discussion 
The complexity of zonal organization of articular cartilage has inspired 
researchers to design multilayered scaffolds. The objective of fabricating this 
bilayered PLCL/chitosan scaffold with distinct pore sizes was to increase the 
mechanical strength at surface while maintaining the overall structural elasticity. 
According to the Young’s modulus and recovery ratio, the mechanical strength of SP 
layer achieved significantly higher value by varying the pore size, while the bilayered 
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scaffold was generally as elastic as the unilayered large pore PLCL/chitosan scaffold 
since the LP layer still constituted the major part of the scaffold. 
 By seeding MSCs to both end of the bilayer scaffold sequentially, similar cell 
distribution in both layers was achieved. Proliferation was not affected by the pore 
size of the scaffold. Given that cells in both layers adopted a similar fibroblastic 
morphology, it is not surprising that cells underwent similar proliferative activity in 
both layers. When comparing the effect of pore size towards chondrogenic 
differentiation of the seeded MSC, expression of cartilaginous markers, AGCAN, COL 
II and PRG4, at week 3 free swelling condition, indicate that LP support better 
differentiation. SP layer, having a pore size of 100–150 µm, compare to the pore size 
of 250–300 µm in the LP layer, might have impeded nutrient supply within the 
scaffold, thus affecting the degree of chondrogenesis. With the formation of ECM 
with longer differentiation period, the initial different in pore size between the bilayer 
scaffold might have diminished, hence the pore size-directed effect in chondrogenesis 
was not as obvious by week 6.  
 The combination of compression and shearing forces in DA loading subjected the 
cells in different layers to experience different mechanical stimulation. The SP layer, 
having the dual-axis force exerted on it, would experience direct shearing force in 
combination of compression loading, similar to the surface of the articular cartilage. 
The LP layer, on the other hand, would experience less of shear, but predominant 
compressional force. The effect of DA mechanical stimulation on cartilage formation 
was analyzed through comparing the expression of chondrogenic markers with those 
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in the bilayered scaffolds under free swelling. AGCAN synthesis was shown to be 
easily modulated by changing the mechanical environment. Recent studies have 
shown that multi-axis stimuli or shearing force was able to stimulate the synthesis of 
AGCAN. However, our findings showed DA loading suppressed expression of 
AGCAN in the SP layer of constructs, in which shearing force was exerted on. 
Although the expression level of COL II showed no significant difference in both 
layers between free swelling and DA loaded groups, the denser organization of COL 
II in SP layer under DA loading was detected, suggestive of enhanced COL II 
deposition, especially in the SP layer under DA stimulation. 
 COL I and PRG4 are markers expressed specifically in cartilage superficial zone. 
The evaluation of COL I and PRG4 mRNA aimed to study whether combined 
compression and shearing forces in DA loading induced zonal distribution in the 
bilayered construct. The overall expression of COLI and PRG4 under DA loading was 
significantly higher than that under free swelling; however, despite a trend of higher 
expression of these two markers in the SP layer, the different was not significant to 
that in the LP layer. The feasible solutions could be either to optimize the amplitude or 
increase the thickness of SP layer. Future work should also look into adopting a 
bioreactor with a rotating shearing that better mimic the physiological movement of 
articular cartilage such as that reported from Grad’s group (Grad et al., 2005), instead 
of a decomposed force as shearing motion in this study.  
 In physiological articular cartilage, the concentration of aggrecan was shown to 
increase from the articular surface with the depth of the cartilage, accounting for the 
97 
 
increasing compressive modulus with the cartilage depth(Saw et al., 2011). On the 
other hand, collagen content does not change significantly with depth. Taken together, 
the pattern of expression of aggrecan and COL II expression in the SP and LP layer 
under DA stimulation ie with enhanced aggrecan in SP relative to LP layer, and the 
up-regulated expression of COL I and PRG4 under DA condition, suggest that DA 
stimulation promoted superficial zone cartilage formation, and a bilayer scaffold with 
differential pore size might be relevant for the generation of zonally distinct cartilage.  
 The study of comparing cartilage formation on either LP or SP layer facing 
shearing force was conducted before the effect of dual-axis physical stimulation was 
investigated. When shearing was loaded on the LP layer, the constructs underwent a 
complete collapse due to the long-term deformation exerted on the LP layers. Thus, 
only the constructs with SP layer facing the force were used to compare the effect of 
dual-axis stimulation on MSC chondrogenic outcome under loading to free swelling. 
This probably implies that material with both high elasticity and rigidity is better 
suited to withstand forces from multiple directions. Hence, the improved bilayered 
PLCL/chitosan scaffold with distinct pore sizes was a progression of the unilayered 
scaffold for long-term dual-axis force and deposit cartilage tissue. 
 In conclusion, the preliminary study of dual-axis mechanical stimulation on MSC 
chondrogenesis on bilayered PLCL/chitosan scaffold shows the potential of scaffold 
manipulation that combines with mechanical stimulation, in achieving heterogenous 
cartilage with zonally distinct phenotype. To generate more defined zonal cartilage in 
the bilayered construct from DA loading, further optimization of loading parameter, 
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employing a bioreactor that mimick more physiological relevant mechanical 
stimulation, and optimization of the bilayered scaffold for mechanical properties that 







7.1Summary of Results 
The main objective of this thesis was to study the influence and mechanism of 
dynamic stimulation towards MSC chondrogenesis. A mechanoactive elastomeric 
PLCL scaffold was fabricated with desirable mechanical and recovery properties.  
The PLCL scaffold was coated with chitosan to improve the surface wettability of the 
scaffold. Scaffold characterisation indicates that chitosan treatment did not affect the 
porosity and mechanical properties of the scaffold, while significantly improved the 
hydrophilicity, which promoted cell spreading, attachment, distribution and possibly 
cell condensation.  Subsequent mRNA and protein expression analysis showed an 
increasing expression of collagen type II and aggrecan in the cell-PLCL/chitosan 
constructs that resulted in improved mechanical properties of the tissue construct. 
These observations indicated that PLCL/chitosan scaffolds possess superior 
characteristics than pure PLCL scaffolds. This finding is fundamentally important 
because this elastomeric PLCL/chitosan scaffold wasthen used for subsequent 
studyon the influence of mechanical stimulation towards MSC chondrogenesis. 
 In the second part of the thesis, deferral dynamic compression was employed to 
the MSC-PLCL/chitosan scaffolds. Compared with free swelling culture, the 
constructs undergoing dynamic compression exhibited a higher extracellular matrix 
deposition and mechanical strength, wherein cells exhibited more chondrogenic-like 
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phenotype. These results proved that dynamic compression is capable of enhancing 
MSC chondrogenesis. Moreover, mRNA and histological analysis of collagen type X 
and matrix metalloproteinase indicated that hypertrophy was suppressed during 
dynamic compression. In addition, the F-actin and integrin β1 distribution showed 
distinct organization between the constructs undergoing dynamic compression and 
free swelling. These findings revealed the need of examining biological mechanism of 
compression-induced hypertrophic suppression. With the investigation of the protein 
level of SMAD2/3 and SMAD1/5/8 phosphorylation, the result suggest that 
TGF-β/Activin/Nodal and BMP/GDP branch in TGF-β/SMAD signaling play 
antagonizing roles in order to modulate hypertrophy. These results were further 
confirmed by inhibiting the receptor of TGF-β, ALK5,the activator of SMAD2/3 
phosphorylation. To elucidate the mechanotransduction mechanism that transduced 
the physical stimulation to intracellular signaling that dictated the suppression of 
hypertrophy, the involvement of integrin (a mechanotransducer) signaling was 
explored. Integrin β1expression was found to besuppressed in the cell constructs 
undergoing dynamic compression. Furthermore, the biomolecules, FAK and ERK in 
integrin β1 pathway were less phosphorylated in the cells under compression. 
Similarly, through the inhibition of integrin β1 in the cells under free swelling, 
up-regulation of hypertrophic markers, MMP13, ALP and RUNX2was suppressed, 
suggesting that integrin β1 expression and signaling could activate hypertrophy. 
Notably, the activation of TGF-β/SMAD2/3 pathway was reciprocal, while the 
activation of BMP/SMAD1/5/8 was associated, to the integrin/FAK/ERK signaling, 
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suggestive of cross-talk between integrin signaling and TGF/SMAD pathways in 
regulating the dynamic compression-controlled hypertrophy development of the 
MSC-derived neo-cartilage. To date, the majority of mechanical stimulation studies 
on chondrogenesis overlooked its connection to hypertrophic suppression or failed to 
avoid hypertrophy in long term culture. Moreover, existing studies on the molecular 
mechanism of chondrogenesis mainly focused on intracellular signal cascades, but 
scarcely investigate the role of outside-in mechanotransduction process. The study in 
this thesis on the molecular mechanism of compression provides a major step 
forwards in the understanding of how mechanical stimuli are transformed to 
biological functions.  
 In the last chapter, the unilayered PLCL/chitosan scaffold was further upgraded 
into a bilayered scaffold according with variable pore sizes. Compared with previous 
unilayered PLCL/chitosan scaffold, the bilayered scaffold was characterized to be 
stiffer but with comparably porosity and elastic. This upgraded scaffold was subjected 
to a dual-axis (DA) loading to better mimic the articular motion (i.e. combination of 
compression and shearing). The evaluation of expression level of chondrogenic 
markers showed a decrease of AGCAN in layer with small pore and stronger signal 
(integrated density) of COL II under DA loading. Further assessments on zonal 
markers, collagen type I and PRG4, revealed significant increase of both markers 
under DA loading. The results suggested that stratified scaffold together with 




 Being a preliminary study using the bilayered scaffold and DA stimulation, this 
work only showed elementary proofs of zonal distribution. Further study is needed to 
further optimize the loading parameter, employing a bioreactor that mimic more 
physiological relevant mechanical stimulation, and optimization of the composition of 
the bilayered scaffold.  
 
7.2 Recommendations for Future Work 
7.2.1 Further Evaluation of Bilayered Scaffold 
The ideal cell constructs for chondrogenesis are more sophisticated than bilayered 
scaffolds. A poresize stratified, component gradient scaffold is recommended to be 
fabricated on the basis of bilayer. Additionally, a refined bioreactor generating 
controllable compressive and shearing forces would be of premier objective. The 
conventional analysis on histological, mRNA and protein level would still be 
necessary to support the idea of constructing zonal distributed cartilage. A detailed 
characterization of the gradient scaffolds is needed: 
1. The overall porosity and elasticity should be tested and remains consistent; 
2. The thickness of each layer is required to be controllable; 
3. More zonal markers, such as CLIP, COL VI and COL IX could be studied to 
support the preliminary finding of zonal distribution. 
In addition to compare the effect of dual-axis stimulation to the free swelling 
condition, comparative functional study on single axis stimulation of compression or 
swearing should be conducted on the bilayered scaffold, to better appreciate the effect 
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of dual-axis stimulation. Investigation of the molecular mechanism elicited by the 
distinct mechanical stimulation on MSC chondrogenesis will provide understanding 





Adam, C., Eckstein F Fau - Milz, S., Milz S Fau - Schulte, E., Schulte E Fau - Becker, 
C., Becker C Fau - Putz, R., & Putz, R. (1998 ). The distribution of cartilage 
thickness in the knee-joints of old-aged individuals -- measurement by A-mode 
ultrasound. Clin Biomech (Bristol, Avon), 13, 1-10.  
AHMED, T. A. & HINCKE, M. T. 2010. Strategies for articular cartilagelesion repair 
and functional restoration. Tissue Eng Part B Rev, 16, 305-29. 
Aigner, T., Frischholz, Svenja, Dertinger, Susanne, Beier, Frank, Girkontaité, Irena, & 
von der Mark, Klaus. (1997). Type X collagen expression and hypertrophic 
differentiation in chondrogenic neoplasias. Histochemistry and Cell Biology, 
107(6), 435-440.  
Amano, M., Chihara, K., Kimura, K., Fukata, Y., Nakamura, N., Matsuura, Y., & 
Kaibuchi, K. (1997). Formation of actin stress fibers and focal adhesions 
enhanced by Rho-kinase. Science, 275(5304), 1308-1311.  
Aszodi, A., Hunziker, E. B., Brakebusch, C., & Fassler, R. (2003). Beta1 integrins 
regulate chondrocyte rotation, G1 progression, and cytokinesis. Genes Dev, 
17(19), 2465-2479.  
Ayala, R., Zhang, C., Yang, D., Hwang, Y., Aung, A., Shroff, S. S., . . . Varghese, S. 
(2011). Engineering the cell-material interface for controlling stem cell adhesion, 
migration, and differentiation. Biomaterials, 32(15), 3700-3711.  
Bang, O. S., Kim, E. J., Chung, J. G., Lee, S. R., Park, T. K., & Kang, S. S. (2000). 
Association of focal adhesion kinase with fibronectin and paxillin is required for 
105 
 
precartilage condensation of chick mesenchymal cells. Biochem Biophys Res 
Commun, 278(3), 522-529. 
Bian, L., Zhai, D. Y., Zhang, E. C., Mauck, R. L., & Burdick, J. A. (2012). Dynamic 
compressive loading enhances cartilage matrix synthesis and distribution and 
suppresses hypertrophy in hMSC-laden hyaluronic acid hydrogels. Tissue Eng 
Part A, 18(7-8), 715-724. doi: 10.1089/ten.TEA.2011.0455 
Billinghurst, R. C., Dahlberg, L., Ionescu, M., Reiner, A., Bourne, R., Rorabeck, 
C., . . . Poole, A. R. (1997). Enhanced cleavage of type II collagen by 
collagenases in osteoarthritic articular cartilage. J Clin Invest, 99(0021-9738 
(Print)), 1534-1545.  
Bobick, B. E., Chen, F. H., Le, A. M., & Tuan, R. S. (2009). Regulation of the 
chondrogenic phenotype in culture. Birth Defects Res C Embryo Today, 87(4), 
351-371.  
Bobick, B. E., & Kulyk, W. M. (2008). Regulation of cartilage formation and 
maturation by mitogen-activated protein kinase signaling. Birth Defects Res C 
Embryo Today, 84(2), 131-154.  
BRITTBERG, M., LINDAHL, A., NILSSON, A., OHLSSON, C.,ISAKSSON, O. & 
PETERSON, L. 1994. Treatment of deep cartilage defectsin the knee with 




Bryant, S. J., & Anseth, K. S. (2002). Hydrogel properties influence ECM production 
by chondrocytes photoencapsulated in poly(ethylene glycol) hydrogels. J Biomed 
Mater Res, 59(1), 63-72.  
Buschmann, M. D., Soulhat, J., Shirazi-Adl, A., Jurvelin, J. S., & Hunziker,E. B., 
(1998).Confined Compression of Articular Cartilage: Linearity in Rampand 
Sinusoidal Tests and the Importance of Interdigitation and 
IncompleteConfinement. J. Biomech., 31, 171–178. 
Chang, S. F., Chang, C. A., Lee, D. Y., Lee, P. L., Yeh, Y. M., Yeh, C. R., . . . Chiu, J. J. 
(2008). Tumor cell cycle arrest induced by shear stress: Roles of integrins and 
Smad. Proc Natl Acad Sci U S A, 105(10), 3927-3932.  
Church, V., Nohno, T., Linker, C., Marcelle, C., & Francis-West, P. (2002). Wnt 
regulation of chondrocyte differentiation. J Cell Sci, 115(Pt 24), 4809-4818.  
Davisson, T., Kunig, S., Chen, A., Sah, R., & Ratcliffe, A. (2002). Static and dynamic 
compression modulate matrix metabolism in tissue engineered cartilage. J Orthop 
Res, 20(4), 842-848.  
DeLise, A. M., Fischer, L., & Tuan, R. S. (2000). Cellular interactions and signaling 
in cartilage development. Osteoarthritis Cartilage, 8(5), 309-334.  
Di Martino, A., Sittinger, M., & Risbud, M. V. (2005). Chitosan: a versatile 
biopolymer for orthopaedic tissue-engineering. Biomaterials, 26(30), 5983-5990.  
Dijke, P., &Arthur, H. M. (2007). Extracellular control of TGFbeta signalling in 
vascular development and disease.Nat Rev Mol Cell Biol, 8(11), 857-69. 
107 
 
Dormer, N. H., Berkland, C. J., & Detamore, M. S. (2010) Emerging Techniques in 
Stratified Designs and Continuous Gradients for Tissue Engineering of Interfaces. 
Ann Biomed Eng, 38(6), 2121–2141. 
Dong, Y. F., Soung do, Y., Schwarz, E. M., O'Keefe, R. J., & Drissi, H. (2006). Wnt 
induction of chondrocyte hypertrophy through the Runx2 transcription factor. J 
Cell Physiol, 208(1), 77-86.  
Duval, E., Bauge, C., Andriamanalijaona, R., Benateau, H., Leclercq, S., Dutoit, S., 
Boumediene, K. (2012). Molecular mechanism of hypoxia-induced 
chondrogenesis and its application in in vivo cartilage tissue engineering. 
Biomaterials, 33(26), 6042-6051.  
Eckstein, F., Lemberger, B., Gratzke, C., Hudelmaier, M., Glaser, C., Englmeier, K. 
H., & Reiser, M. (2005). In vivo cartilage deformation after different types of 
activity and its dependence on physical training status. Ann Rheum Dis, 64(2), 
291-295.  
Edwards, P. K., Ackland, T., & Ebert, J. R. (2014). Clinical rehabilitation guidelines 
for matrix-induced autologous chondrocyte implantation on the tibiofemoral joint. 
J Orthop Sports Phys Ther, 44(2), 102-119.  
Fernandez, J., Etxeberria, A., & Sarasua, J. R. (2012). Synthesis, structure and 
properties of poly(L-lactide-co-epsilon-caprolactone) statistical copolymers. J 
Mech Behav Biomed Mater, 9, 100-112. 
108 
 
Fischer, L., Boland, G., & Tuan, R. S. (2002). Wnt-3A enhances bone morphogenetic 
protein-2-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cells. J 
Biol Chem, 277(34), 30870-30878. 
Foletta, V. C., Lim, M. A., Soosairajah, J., Kelly, A. P., Stanley, E. G., Shannon, M., 
Bernard, O. (2003). Direct signaling by the BMP type II receptor via the 
cytoskeletal regulator LIMK1. J Cell Biol, 162(6), 1089-1098.  
Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & 
Semenza, G. L. (1996). Activation of vascular endothelial growth factor gene 
transcription by hypoxia-inducible factor 1. Mol Cell Biol, 16(9), 4604-4613.  
Fox, A. S., Bedi, A., & Rodeo, S. A., (2009). The Basic Science of Articular 
Cartilage:Structure, Composition, and Function. Sports Health, 1, 461-468. 
Gadjanski, I., Spiller, K., & Vunjak-Novakovic, G. (2011). Time-dependent processes 
in stem cell-based tissue engineering of articular cartilage. Stem Cell Rev, 8(3), 
863-881.  
Gawlitta, D., van Rijen, Mh. Fau, Schrijver, Ej. , Alblas, J. , & Dhert, W. J. (2012). 
Hypoxia impedes hypertrophic chondrogenesis of human multipotent stromal 
cells. Tissue Eng Part A, 18, 1957-1966.  
Gelse, K., Pfander, D., Obier, S., Knaup, K. X., Wiesener, M., Hennig, F. F., & 
Swoboda, B. (2008). Role of hypoxia-inducible factor 1 alpha in the integrity of 
articular cartilage in murine knee joints. Arthritis Res Ther, 10(5), R111.  
Giancotti, F. G. (1999). Integrin Signaling. Science, 285(5430), 1028-1033.  
109 
 
Gnecchi, M., & Melo, L. G. (2009). Bone marrow-derived mesenchymal stem cells: 
isolation, expansion, characterization, viral transduction, and production of 
conditioned medium. Methods Mol Biol, 482, 281-294.  
Goldring, M. B., Tsuchimochi, K., & Ijiri, K. (2006). The control of chondrogenesis. J 
Cell Biochem, 97(1), 33-44.  
Grad, S., Eglin D Fau - Alini, Mauro, Alini M Fau - Stoddart, Martin J., & Stoddart, 
M. J. (2011). Physical stimulation of chondrogenic cells in vitro: a review. Clin 
Orthop Relat Res, 469(10), 2764-2772.  
Grad, S., Lee, C. R., Gorna, K., Gogolewski, S., Wimmer, M. A., & Alini, M. (2005). 
Surface motion upregulates superficial zone protein and hyaluronan production in 
chondrocyte-seeded three-dimensional scaffolds. Tissue Eng, 11(1-2), 249-256. 
Grodzinsky, A. L., Kim, Y. J., Buschmann, M. D., Garcia, A. M., Quinn, T. M., & 
Hunziker, E. B., (1998). ‘‘Response of the Chondrocyte to Mechanical Stimuli,’’ 
in: Osteoarthritis, K. D. Brandt et al., eds., pp. 123–136. 
Grodzinsky, A. J., Levenston, M. E., Jin, M., & Frank, E. H. (2000). Cartilage tissue 
remodeling in response to mechanical forces. Annu Rev Biomed Eng, 2, 691-713.  
Habuchi, H., Conrad, H. E., & Glaser, J. H. (1985). Coordinate regulation of collagen 
and alkaline phosphatase levels in chick embryo chondrocytes. J Biol Chem, 
260(24), 13029-13034.  
Halper, J., & Kjaer, M. (2014). Basic components of connective tissues and 
extracellular matrix: elastin, fibrillin, fibulins, fibrinogen, fibronectin, laminin, 
110 
 
tenascins and thrombospondins. Adv Exp Med Biol, 802(0065-2598 (Print)), 
31-47.  
Harburger, D. S., & Calderwood, D. A. (2009). Integrin signalling at a glance. Journal 
of Cell Science, 122(2), 159-163.  
Haugh, M. G., Meyer, E., Thorpe, S., Vinardell, T., Duffy, G., & Kelly, D. J. (2011). 
Temporal and spatial changes in cartilage-matrix-specific gene expression in 
mesenchymal stem cells in response to dynamic compression. Tissue Eng Part A, 
17(23-24), 3085–3093.  
Hayes, A. J., Hall, A., Brown, L., Tubo, R. & Caterson, B. (2007). Macromolecular 
organization and in vitro growth characteristics ofscaffold-free neocartilage grafts. 
Journal of Histochemistry &Cytochemistry, 55, 853-866. 
Hayes, W. F., & Mockros, L. F. (1971). Viscoelastic properties of human articular 
cartilage. J Appl Physiol, 31(4), 562-568.  
Hellingman, C. A., Davidson, E. N. B., Koevoet, W., Vitters, E. L., van den Berg, W. 
B., van Osch, Gjvm, & van der Kraan, P. M. (2011). Smad Signaling Determines 
Chondrogenic Differentiation of Bone-Marrow-Derived Mesenchymal Stem 
Cells: Inhibition of Smad1/5/8P Prevents Terminal Differentiation and 
Calcification. Tissue Eng Part A, 17(7-8), 1157-1167.  
Hirsch, M. S., Lunsford, L. E., Trinkaus-Randall, V., & Svoboda, K. K. (1997). 
Chondrocyte survival and differentiation in situ are integrin mediated. Dev Dyn, 
210(3), 249-263.  
111 
 
Huang, A. H., Farrell, M. J., & Mauck, R. L. (2010). Mechanics and mechanobiology 
of mesenchymal stem cell-based engineered cartilage. J Biomech, 43(1), 
128-136.  
Huang, A. H., Farrell, M., Kim, M., & Mauck, R. L. (2010). Long-term dynamic 
loading improves the mechanical properties of chondrogenic mesenchymal stem 
cell-laden hydrogel. Eur Cell Mater, 19(72-85). 
Hunziker, E. B., Quinn, T. F., & Hauselmann, H. J. (2002). Quantitative structural 
organization of normal adult human articular cartilage. Osteoarthritis Cartilage, 
10(7), 564-572.  
Hynes, R. O. (2002). Integrins: bidirectional, allosteric signaling machines. Cell, 110, 
673-687.  
Inman, G. J., Nicolas, F., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., 
Hill, C. S. (2002). SB-431542 is a potent and specific inhibitor of transforming 
growth factor-beta superfamily type I activin receptor-like kinase (ALK) 
receptors ALK4, ALK5, and ALK7. Mol Pharmacol, 62, 65-74.  
Izadifar, Z., Chen, X., &Kulyk, W. (2012). Strategic Design and Fabrication of 
Engineered Scaffolds for Articular Cartilage Repair. J Funct Biomater, 3(4), 
799-838. 
Javed, A., Bae, J. S., Afzal, F., Gutierrez, S., Pratap, J., Zaidi, S. K., Lian, J. B. (2008). 
Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic 
signal. J Biol Chem, 283(13), 8412-8422.  
112 
 
Jin, E. J., Choi, Y. A., Kyun Park, E., Bang, O. S., & Kang, S. S. (2007). MMP-2 
functions as a negative regulator of chondrogenic cell condensation via 
down-regulation of the FAK-integrin beta1 interaction. Dev Biol, 308(2), 
474-484.  
Johnson, K. A., Rose, D. M., & Terkeltaub, R. A. (2008). Factor XIIIA mobilizes 
transglutaminase 2 to induce chondrocyte hypertrophic differentiation. J Cell Sci, 
121(Pt 13), 2256-2264.  
Kempson, G. F., Muir, H., Swanson, S. A., & Freeman, M. A. (1970). Correlations 
between stiffness and the chemical constituents of cartilage on the human femoral 
head. Biochim Biophys Acta, 215(1), 70-77.  
Kim, D. K., Kim, S. J., Kang, S. S., & Jin, E. J. (2009). Curcumin inhibits cellular 
condensation and alters microfilament organization during chondrogenic 
differentiation of limb bud mesenchymal cells. Exp Mol Med, 41(9), 656-664. 
Kopesky, P. W., Vanderploeg, E. J., Kisiday, J. D., Frisbie, D. D., Sandy, J. D., & 
Grodzinsky, A. J. (2011). Controlled Delivery of Transforming Growth Factor 
beta 1 by Self-Assembling Peptide Hydrogels Induces Chondrogenesis of Bone 
Marrow Stromal Cells and Modulates Smad2/3 Signaling. Tissue Eng Part A, 
17(1-2), 83-92.  
Kronenberg, H. M., & Chung, U. (2001). The parathyroid hormone-related protein 
and Indian hedgehog feedback loop in the growth plate. Novartis Found Symp, 
232, 144-152; discussion 152-147.  
113 
 
Lee, O. K., Kuo, T. , Chen, W. , Lee, K. , Hsieh, S. l., & Chen, T. H. (2004). Isolation 
of multipotent mesenchymal stem cells from umbilical cord blood. Blood, 
2004(5), 1669-1675.  
Li, C., Wang, L., Yang, Z., Kim, G., Chen, H., &Ge, Z. (2012). A viscoelastic 
chitosan-modified three-dimensional porous poly(L-lactide-co-ε-caprolactone) 
scaffold for cartilage tissue engineering. J Biomater Sci Polym Ed, 23(1-4), 
405-24. 
Li, J., Wang, J., Zou, Y., Zhang, Y., &Zhao, Z. (2012). The influence of delayed 
compressive stress on TGF-β1-induced chondrogenic differentiation of rat 
BMSCs through Smad-dependent and Smad-independent pathways. Biomaterials, 
33(33), 8395-8405.  
Liu, H., Peng, H., Wu, Y., Zhang, C., Cai, Y., Xu, G., OuYang, H. W. (2013). The 
promotion of bone regeneration by nanofibrous hydroxyapatite/chitosan scaffolds 
by effects on integrin-BMP/Smad signaling pathway in BMSCs. Biomaterials, 
34(18), 4404-4417.  
Lucic, D., Mollenhauer, J., Katherine, E., Kilpatrick, K., & Cole, A. A. (2003). 
N-telopeptide of type II collagen interacts with annexin V on human 
chondrocytes. Connect Tissue Res, 44, 225-239.  
Mackie, E. J., Ahmed, Y. A., Tatarczuch, L., Chen, K. S., & Mirams, M. (2008). 
Endochondral ossification: How cartilage is converted into bone in the 
developing skeleton. The International Journal of Biochemistry & Cell Biology, 
40(1), 46-62.  
114 
 
Mahmoudifar, Nastaran, & Doran, Pauline M. (2012). Chondrogenesis and cartilage 
tissue engineering: the longer road to technology development. Trends Biotechnol, 
30(3), 166-176.  
J. M. Mansour. Biomechanics of cartilage. In C. A. Oatis,editor,Kinesiology: The 
Mechanics andPathomechanics of Human Movement, chapter 5, Lippincott 
Williams and Wilkins, 2004, pp. 66–79. 
Martin, I., Wendt, D., & Heberer, M. (2004). The role of bioreactors in tissue 
engineering. Trends Biotechnol, 22(2), 80-86.  
Massague, J. (2000). How cells read TGF-beta signals. Nat Rev Mol Cell Biol, 1(3), 
169-178.  
Matsiko, A., Levingstone, T., & O'Brien, F. (2013). Advanced Strategies for Articular 
Cartilage Defect Repair. Materials, 6(2), 637-668.  
McCullen, S. D., Autefage, H., Callanan, A., Gentleman, E., & Stevens, M. M. (2012). 
Anisotropic fibrous scaffolds for articular cartilage regeneration. Tissue Eng Part 
A, 18(19-20), 2073-2083.  
Millward-Sadler, S. J., & Salter, D. M. (2004). Integrin-dependent signal cascades in 
chondrocyte mechanotransduction. Annals of Biomedical Engineering, 32(3), 
435-446.  
Mizuno, H., Tobita, M., & Uysal, A. C. (2012). Concise review: Adipose-derived stem 
cells as a novel tool for future regenerative medicine. Stem Cells, 30(5), 804-810.  
115 
 
Mobasheri, A., Carter, S., Martin-Vasallo, P., & Shakibaei, M. (2002). Integrins and 
stretch activated ion channels; putative components of functional cell surface 
mechanoreceptors in articular chondrocytes. Cell Biol Int, 26, 1-18.  
Moutos, F. T., & Guilak, F. (2008). Composite scaffolds for cartilage tissue 
engineering. Biorheology, 45(3-4), 501-512.  
Mouw, Janna K., Connelly, John T., Wilson, Christopher G., Michael, Kristin E., & 
Levenston, Marc E. (2007). Dynamic Compression Regulates the Expression and 
Synthesis of Chondrocyte-Specific Matrix Molecules in Bone Marrow Stromal 
Cells. Stem Cells, 25(3), 655-663.  
Mow, V. F., Holmes, M. H., & Lai, W. M. (1984). Fluid transport and mechanical 
properties of articular cartilage: a review. J Biomech, 17(5), 377-394.  
Mueller, M. B., & Tuan, R. S. (2008). Functional characterization of hypertrophy in 
chondrogenesis of human mesenchymal stem cells. Arthritis Rheum, 58, 
1377-1388.  
Muir, Helen. (1995). The chondrocyte, architect of cartilage. Biomechanics, structure, 
function and molecular biology of cartilage matrix macromolecules. BioEssays, 
17(12), 1039-1048.  
Ng, K. W., Mauck, R. L., Statman, L. Y., Lin, E. Y., Ateshian, G. A., & Hung, C. T. 
(2006). Dynamic deformational loading results in selective application of 
mechanical stimulation in a layered, tissue-engineered cartilage construct. 
Biorheology, 43(3-4), 497-507.  
116 
 
Nguyen, L. H., Kudva, A. K., Guckert, N. L., Linse, K. D., & Roy, K. (2011). Unique 
biomaterial compositions direct bone marrow stem cells into specific 
chondrocytic phenotypes corresponding to the various zones of articular cartilage. 
Biomaterials, 32(5), 1327-1338.  
Nishimura, R., Wakabayashi, M., Hata, K., Matsubara, T., Honma, S., Wakisaka, S., 
Yoneda, T. (2012). Osterix regulates calcification and degradation of 
chondrogenic matrices through matrix metalloproteinase 13 (MMP13) expression 
in association with transcription factor Runx2 during endochondral ossification. J 
Biol Chem, 287, 33179-33190.  
O'Conor, C. J., Case, N., & Guilak, F. (2013). Mechanical regulation of 
chondrogenesis. Stem Cell Res Ther, 4(4), 61.  
Oeckinghaus, A., & Ghosh, S. (2009). The NF-kappaB family of transcription factors 
and its regulation. Cold Spring Harb Perspect Biol, 1(4), a000034. 
Oh, Jung Kwon. (2011). Polylactide (PLA)-based amphiphilic block copolymers: 
synthesis, self-assembly, and biomedical applications. Soft Matter, 7(11), 
5096-5108.  
Parkkinen, J. J., Ikonen, J., Lammi, M. J., Laakkonen, J., Tammi, M., & Helminen, H. 
J. (1993). Effects of cyclic hydrostatic pressure on proteoglycan synthesis in 
cultured chondrocytes and articular cartilage explants. Arch Biochem Biophys, 
300(1), 458-465.  
Prasadam, I., van Gennip, S., Friis, T., Shi, W., Crawford, R., & Xiao, Y. (2010). 
ERK-1/2 and p38 in the regulation of hypertrophic changes of normal articular 
117 
 
cartilage chondrocytes induced by osteoarthritic subchondral osteoblasts. Arthritis 
Rheum, 62(5), 1349-1360.  
Prasitsilp, M., Jenwithisuk, R., Kongsuwan, K., Damrongchai, N., & Watts, P. (2000). 
Cellular responses to chitosan in vitro: The importance of deacetylation. J Mater 
Sci-Mater M, 11(12), 773-778. 
Raghothaman, Deepak, Leong, Meng Fatt, Lim, Tze Chiun, Toh, Jerry K. C., Wan, 
Andrew C. A., Yang, Zheng, & Lee, Eng Hin. (2014). Engineering cell matrix 
interactions in assembled polyelectrolyte fiber hydrogels for mesenchymal stem 
cell chondrogenesis. Biomaterials, 35(9), 2607-2616. 
Responte, D. J., Lee, J., Hu, J. C., & Athanasiou, K. A. (2012). Biomechanics-driven 
chondrogenesis: from embryo to adult. FASEB J, 26(9), 3614-3624.  
Rigoglou, S., & Papavassiliou, A. G. (2013). The NF-kappaB signalling pathway in 
osteoarthritis. Int J Biochem Cell Biol, 45(11), 2580-2584. 
Sah, R. L., Kim, Y. J., Doong, J. Y., Grodzinsky, A. J., Plaas, A. H., & Sandy, J. D. 
(1989). Biosynthetic response of cartilage explants to dynamic compression. J 
Orthop Res, 7(5), 619-636. 
Saleem, S., Li, J., Yee, S. P., Fellows, G. F., Goodyer, C. G., & Wang, R. (2009). beta1 
integrin/FAK/ERK signalling pathway is essential for human fetal islet cell 
differentiation and survival. J Pathol, 219(2), 182-192.  
Saw, K. Y., Anz, A., Merican, S., Tay, Y. G., Ragavanaidu, K., Jee, C. S., & McGuire, 
D. A. (2011). Articular cartilage regeneration with autologous peripheral blood 
118 
 
progenitor cells and hyaluronic acid after arthroscopic subchondral drilling: a 
report of 5 cases with histology. Arthroscopy, 27(4), 493-506.  
Schatti, O., Grad S Fau - Goldhahn, J., Goldhahn J Fau - Salzmann, G., Salzmann G 
Fau - Li, Z., Li Z Fau - Alini, M., Alini M Fau - Stoddart, M. J., & Stoddart, M. J. 
(2011). A combination of shear and dynamic compression leads to mechanically 
induced chondrogenesis of human mesenchymal stem cells. Eur Cell Mater, 22, 
214-125.  
Schatti, O., Grad, S., Goldhahn, J., Salzmann, G., Li, Z., Alini, M., & Stoddart, M. J. 
(2011). A combination of shear and dynamic compression leads to mechanically 
induced chondrogenesis of human mesenchymal stem cells. Eur Cell Mater, 22, 
214-225.  
Schmierer, B., & Hill, C. S. (2007). TGFbeta-SMAD signal transduction: molecular 
specificity and functional flexibility. Nat Rev Mol Cell Biol, 8(12), 970-982. 
Sekiya, I., Tsuji, K., Koopman, P., Watanabe, H., Yamada, Y., Shinomiya, K., Noda, 
M. (2000). SOX9 enhances aggrecan gene promoter/enhancer activity and is 
up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J Biol Chem, 
275(15), 10738-10744.  
Smith, G. D., Knutsen, G., & Richardson, J. B. (2005). A clinical review of cartilage 
repair techniques. J Bone Joint Surg Br, 87B(4), 445-449.  
Sophia Fox, A. J., Bedi, A., & Rodeo, S. A. (2009). The basic science of articular 
cartilage: structure, composition, and function. Sports Health, 1(6), 461-468.  
119 
 
Stains, Joseph P., & Civitelli, Roberto. (2005). Cell-to-cell interactions in bone. 
Biochemical and Biophysical Research Communications, 328(3), 721-727.  
Steele, J. A., McCullen, S. D., Callanan, A., Autefage, H., Accardi, M. A., Dini, D., 
&Stevens, M. M. (2014).Combinatorial scaffold morphologies for zonal articular 
cartilage engineering.Acta Biomater,10(5), 2065-75. 
Stoddart, M. J., Ettinger, L., &Hauselmann, H. J. (2006). Enhanced matrix synthesis 
indenovo, scaffold freecartilage-like tissue subjected to compression and 
shear.Biotechnol Bioeng, 95, 1043-1051. 
Studer, D., Millan, C., Öztürk, E., Maniura-Weber, K.,&Marcy Zenobi-Wong, 
M.(2012). Molecularand biophysical mechanisms regulating hypertrophic 
differentiation in chondrocytes and mesenchymal stem cell. European cells and 
materials, 24, 118-135. 
Takada, Y., Ye, X., & Simon, S. (2007). The integrins. Genome Biol, 8(5), 215.  
Takahashi, I. (2003). Effect of stretching on gene expression of beta1 integrin and 
focal adhesion kinase and on chondrogenesis through cell-extracellular matrix 
interactions. Eur J Cell Biol, 82(4), 182-192.  
Tuli, R., Tuli, S., Nandi, S., Huang, X., Manner, P. A., Hozack, W. J., Tuan, R. S. 
(2003). Transforming growth factor-beta-mediated chondrogenesis of human 
mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein 
kinase and Wnt signaling cross-talk. J Biol Chem, 278(42), 41227-41236.  
120 
 
Verteramo, A., & Seedhom, B. B. (2007). Effect of a single impact loading on the 
structure and mechanical properties of articular cartilage. J Biomech, 40(16), 
3580-3589.  
Vinardell, T., Rolfe, R. A., Buckley, C. T., Meyer, E. G., Ahearne, M., Murphy, P., & 
Kelly, D. J. (2012). Hydrostatic pressure acts to stabilise a chondrogenic 
phenotype in porcine joint tissue derived stem cells. Eur Cell Mater, 23, 121-132.  
Waldman, S. D., Couto, D. C., Grynpas, M. D., Pilliar, R. M., Kandel, R. A. (2007). 
Multi-axial mechanical stimulation of tissue engineered cartilage: review.Eur Cell 
Mater. 13:66-75. 
Waldman, S. D., Spiteri, C. G., Grynpas, M. D., Pilliar, R. M., & Kandel, R. A. (2004). 
Long-term intermittent compressive stimulation improves the composition and 
mechanical properties of tissue-engineered cartilage. Tissue Eng, 10(9-10), 
1323-1331.  
Wang, W., Rigueur D Fau - Lyons, Karen M., & Lyons, K. M. (2014). TGFbeta 
signaling in cartilage development and maintenance. Birth Defects Res C Embryo 
Today, 102, 37-51.  
Wong, M., Siegrist, M., & Cao, X. (1999). Cyclic compression of articular cartilage 
explants is associated with progressive consolidation and altered expression 
pattern of extracellular matrix proteins. Matrix Biol, 18(4), 391-399.  
Woods, Anita, Wang, Guoyan, & Beier, Frank. (2007). Regulation of chondrocyte 
differentiation by the actin cytoskeleton and adhesive interactions. J Cell Physiol, 
213(1), 1-8.  
121 
 
Yang, Z., Zou, Y., Guo, X. M., Tan, H. S., Denslin, V., Yeow, C. H.,Lee, E. H. (2012). 
Temporal activation of beta-catenin signaling in the chondrogenic process of 
mesenchymal stem cells affects the phenotype of the cartilage generated. Stem 
Cells Dev, 21(11), 1966-1976.  
Yano, F., Kugimiya, F., Ohba, S., Ikeda, T., Chikuda, H., Ogasawara, T.,Chung, U. I. 
(2005). The canonical Wnt signaling pathway promotes chondrocyte 
differentiation in a Sox9-dependent manner. Biochem Biophys Res Commun, 
333(4), 1300-1308.  
Zarubin, T., & Han, J. (2005). Activation and signaling of the p38 MAP kinase 
pathway. Cell Res, 15(1), 11-18. doi: 10.1038/sj.cr.7290257 
Zhang, C., Tang, W., & Li, Y. (2012). Matrix metalloproteinase 13 (MMP13) is a 
direct target of osteoblast-specific transcription factor osterix (Osx) in osteoblasts. 
PLoS One, 7, e50525.  
Zheng, Q., Zhou G., Morello R., Chen Y., Xavier, Garcia-Rojas X & Lee, B. (2003 ). 
Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic 






Fig S. An example of Stress-Strain graph of PLCL/chitosan cell construct. 
 
 
